EP1100431A1 - Finely dispersed emulsifier-free systems of the oil-in-water and water-in-oil type - Google Patents
Finely dispersed emulsifier-free systems of the oil-in-water and water-in-oil typeInfo
- Publication number
- EP1100431A1 EP1100431A1 EP99936590A EP99936590A EP1100431A1 EP 1100431 A1 EP1100431 A1 EP 1100431A1 EP 99936590 A EP99936590 A EP 99936590A EP 99936590 A EP99936590 A EP 99936590A EP 1100431 A1 EP1100431 A1 EP 1100431A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- oil
- water
- preparations
- cosmetic
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title claims abstract description 29
- 238000002360 preparation method Methods 0.000 claims abstract description 56
- 239000002245 particle Substances 0.000 claims abstract description 53
- 239000002537 cosmetic Substances 0.000 claims abstract description 42
- 229920000642 polymer Polymers 0.000 claims abstract description 32
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 24
- 239000007787 solid Substances 0.000 claims abstract description 16
- 239000004480 active ingredient Substances 0.000 claims abstract description 14
- 239000000126 substance Substances 0.000 claims description 35
- 239000003921 oil Substances 0.000 claims description 25
- 239000000203 mixture Substances 0.000 claims description 19
- 239000000049 pigment Substances 0.000 claims description 17
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims description 12
- 239000003963 antioxidant agent Substances 0.000 claims description 12
- 229910052582 BN Inorganic materials 0.000 claims description 11
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 11
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 11
- PZNSFCLAULLKQX-UHFFFAOYSA-N Boron nitride Chemical compound N#B PZNSFCLAULLKQX-UHFFFAOYSA-N 0.000 claims description 10
- 206010000496 acne Diseases 0.000 claims description 10
- 239000013543 active substance Substances 0.000 claims description 10
- 208000002874 Acne Vulgaris Diseases 0.000 claims description 9
- 150000004676 glycans Chemical class 0.000 claims description 9
- 229920001282 polysaccharide Polymers 0.000 claims description 9
- 239000005017 polysaccharide Substances 0.000 claims description 9
- 229910044991 metal oxide Inorganic materials 0.000 claims description 7
- 150000004706 metal oxides Chemical class 0.000 claims description 7
- 239000011787 zinc oxide Substances 0.000 claims description 6
- 239000001023 inorganic pigment Substances 0.000 claims description 5
- 239000004408 titanium dioxide Substances 0.000 claims description 5
- 239000000654 additive Substances 0.000 claims description 4
- 239000000377 silicon dioxide Substances 0.000 claims description 4
- 235000012239 silicon dioxide Nutrition 0.000 claims description 4
- 230000000845 anti-microbial effect Effects 0.000 claims description 3
- 239000003212 astringent agent Substances 0.000 claims description 3
- 150000004760 silicates Chemical class 0.000 claims description 3
- 230000006750 UV protection Effects 0.000 claims description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N iron oxide Inorganic materials [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 claims 2
- 235000013980 iron oxide Nutrition 0.000 claims 2
- VBMVTYDPPZVILR-UHFFFAOYSA-N iron(2+);oxygen(2-) Chemical class [O-2].[Fe+2] VBMVTYDPPZVILR-UHFFFAOYSA-N 0.000 claims 2
- 239000011814 protection agent Substances 0.000 claims 1
- 239000012071 phase Substances 0.000 abstract description 14
- 239000008346 aqueous phase Substances 0.000 abstract description 3
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 2
- 239000000839 emulsion Substances 0.000 description 36
- -1 polyoxyethylene Polymers 0.000 description 29
- 235000019198 oils Nutrition 0.000 description 17
- 210000003491 skin Anatomy 0.000 description 16
- 229920002472 Starch Polymers 0.000 description 13
- 150000002148 esters Chemical group 0.000 description 12
- 229940032147 starch Drugs 0.000 description 12
- 235000019698 starch Nutrition 0.000 description 12
- 239000008107 starch Substances 0.000 description 12
- 235000006708 antioxidants Nutrition 0.000 description 11
- 239000002781 deodorant agent Substances 0.000 description 10
- 239000007788 liquid Substances 0.000 description 10
- 235000002639 sodium chloride Nutrition 0.000 description 10
- 150000003839 salts Chemical class 0.000 description 9
- FFFHZYDWPBMWHY-VKHMYHEASA-N L-homocysteine Chemical compound OC(=O)[C@@H](N)CCS FFFHZYDWPBMWHY-VKHMYHEASA-N 0.000 description 8
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 8
- 150000003457 sulfones Chemical class 0.000 description 8
- 150000001875 compounds Chemical class 0.000 description 7
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 7
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 150000002170 ethers Chemical class 0.000 description 6
- 238000009472 formulation Methods 0.000 description 6
- 150000002632 lipids Chemical class 0.000 description 6
- 239000011734 sodium Substances 0.000 description 6
- 229910052708 sodium Inorganic materials 0.000 description 6
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 235000017471 coenzyme Q10 Nutrition 0.000 description 5
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 5
- 239000004205 dimethyl polysiloxane Substances 0.000 description 5
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 5
- 239000003925 fat Substances 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 244000005700 microbiome Species 0.000 description 5
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 5
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 5
- 210000004243 sweat Anatomy 0.000 description 5
- 235000010215 titanium dioxide Nutrition 0.000 description 5
- 229940035936 ubiquinone Drugs 0.000 description 5
- 235000014692 zinc oxide Nutrition 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 229920000299 Nylon 12 Polymers 0.000 description 4
- 229920002292 Nylon 6 Polymers 0.000 description 4
- 229910010413 TiO 2 Inorganic materials 0.000 description 4
- 239000004904 UV filter Substances 0.000 description 4
- 230000001166 anti-perspirative effect Effects 0.000 description 4
- 239000003213 antiperspirant Substances 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 235000019197 fats Nutrition 0.000 description 4
- 230000000670 limiting effect Effects 0.000 description 4
- 230000004224 protection Effects 0.000 description 4
- 230000005855 radiation Effects 0.000 description 4
- 230000006641 stabilisation Effects 0.000 description 4
- 238000011105 stabilization Methods 0.000 description 4
- 239000000516 sunscreening agent Substances 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 150000003722 vitamin derivatives Chemical class 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 239000004952 Polyamide Substances 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- 230000004888 barrier function Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 125000002091 cationic group Chemical group 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 239000010410 layer Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 229920002647 polyamide Polymers 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 229910010271 silicon carbide Inorganic materials 0.000 description 3
- 208000017520 skin disease Diseases 0.000 description 3
- 230000000087 stabilizing effect Effects 0.000 description 3
- 230000000475 sunscreen effect Effects 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 239000002562 thickening agent Substances 0.000 description 3
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 2
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 2
- CRDAMVZIKSXKFV-YFVJMOTDSA-N (2-trans,6-trans)-farnesol Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CO CRDAMVZIKSXKFV-YFVJMOTDSA-N 0.000 description 2
- OIQXFRANQVWXJF-QBFSEMIESA-N (2z)-2-benzylidene-4,7,7-trimethylbicyclo[2.2.1]heptan-3-one Chemical class CC1(C)C2CCC1(C)C(=O)\C2=C/C1=CC=CC=C1 OIQXFRANQVWXJF-QBFSEMIESA-N 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 2
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- 208000035985 Body Odor Diseases 0.000 description 2
- 241000723346 Cinnamomum camphora Species 0.000 description 2
- 241000186427 Cutibacterium acnes Species 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- 206010020649 Hyperkeratosis Diseases 0.000 description 2
- 229940124091 Keratolytic Drugs 0.000 description 2
- BYBLEWFAAKGYCD-UHFFFAOYSA-N Miconazole Chemical compound ClC1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 BYBLEWFAAKGYCD-UHFFFAOYSA-N 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- 206010040904 Skin odour abnormal Diseases 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 239000006096 absorbing agent Substances 0.000 description 2
- LZCDAPDGXCYOEH-UHFFFAOYSA-N adapalene Chemical compound C1=C(C(O)=O)C=CC2=CC(C3=CC=C(C(=C3)C34CC5CC(CC(C5)C3)C4)OC)=CC=C21 LZCDAPDGXCYOEH-UHFFFAOYSA-N 0.000 description 2
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 2
- ANVAOWXLWRTKGA-XHGAXZNDSA-N all-trans-alpha-carotene Chemical compound CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1C(C)=CCCC1(C)C ANVAOWXLWRTKGA-XHGAXZNDSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 2
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 2
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 2
- 125000000129 anionic group Chemical group 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- CUFNKYGDVFVPHO-UHFFFAOYSA-N azulene Chemical compound C1=CC=CC2=CC=CC2=C1 CUFNKYGDVFVPHO-UHFFFAOYSA-N 0.000 description 2
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical compound CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 2
- 229940036350 bisabolol Drugs 0.000 description 2
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 229960000846 camphor Drugs 0.000 description 2
- 229930008380 camphor Natural products 0.000 description 2
- 229940044199 carnosine Drugs 0.000 description 2
- 150000001746 carotenes Chemical class 0.000 description 2
- 235000005473 carotenes Nutrition 0.000 description 2
- 239000000919 ceramic Substances 0.000 description 2
- LVYZJEPLMYTTGH-UHFFFAOYSA-H dialuminum chloride pentahydroxide dihydrate Chemical compound [Cl-].[Al+3].[OH-].[OH-].[Al+3].[OH-].[OH-].[OH-].O.O LVYZJEPLMYTTGH-UHFFFAOYSA-H 0.000 description 2
- WMWXXXSCZVGQAR-UHFFFAOYSA-N dialuminum;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3] WMWXXXSCZVGQAR-UHFFFAOYSA-N 0.000 description 2
- 229940008099 dimethicone Drugs 0.000 description 2
- AMTWCFIAVKBGOD-UHFFFAOYSA-N dioxosilane;methoxy-dimethyl-trimethylsilyloxysilane Chemical compound O=[Si]=O.CO[Si](C)(C)O[Si](C)(C)C AMTWCFIAVKBGOD-UHFFFAOYSA-N 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 239000003792 electrolyte Substances 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- JBKVHLHDHHXQEQ-UHFFFAOYSA-N epsilon-caprolactam Chemical compound O=C1CCCCCN1 JBKVHLHDHHXQEQ-UHFFFAOYSA-N 0.000 description 2
- 238000006266 etherification reaction Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 description 2
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 2
- 235000020664 gamma-linolenic acid Nutrition 0.000 description 2
- 229960002733 gamolenic acid Drugs 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 210000003780 hair follicle Anatomy 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- 230000001530 keratinolytic effect Effects 0.000 description 2
- 239000003410 keratolytic agent Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000000391 magnesium silicate Substances 0.000 description 2
- AHXDSVSZEZHDLV-UHFFFAOYSA-N mesulfen Chemical compound CC1=CC=C2SC3=CC(C)=CC=C3SC2=C1 AHXDSVSZEZHDLV-UHFFFAOYSA-N 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 239000002777 nucleoside Substances 0.000 description 2
- 125000003835 nucleoside group Chemical group 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 239000007764 o/w emulsion Substances 0.000 description 2
- 230000009965 odorless effect Effects 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 235000021313 oleic acid Nutrition 0.000 description 2
- 230000036542 oxidative stress Effects 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 239000004417 polycarbonate Substances 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 229940055019 propionibacterium acne Drugs 0.000 description 2
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 239000005871 repellent Substances 0.000 description 2
- JZWFDVDETGFGFC-UHFFFAOYSA-N salacetamide Chemical group CC(=O)NC(=O)C1=CC=CC=C1O JZWFDVDETGFGFC-UHFFFAOYSA-N 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 229940083037 simethicone Drugs 0.000 description 2
- 238000004381 surface treatment Methods 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 235000012222 talc Nutrition 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 230000008719 thickening Effects 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- CRDAMVZIKSXKFV-UHFFFAOYSA-N trans-Farnesol Natural products CC(C)=CCCC(C)=CCCC(C)=CCO CRDAMVZIKSXKFV-UHFFFAOYSA-N 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- 239000003981 vehicle Substances 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- 239000007762 w/o emulsion Substances 0.000 description 2
- HEOCBCNFKCOKBX-RELGSGGGSA-N (1s,2e,4r)-4,7,7-trimethyl-2-[(4-methylphenyl)methylidene]bicyclo[2.2.1]heptan-3-one Chemical compound C1=CC(C)=CC=C1\C=C/1C(=O)[C@]2(C)CC[C@H]\1C2(C)C HEOCBCNFKCOKBX-RELGSGGGSA-N 0.000 description 1
- 239000000260 (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol Substances 0.000 description 1
- DBSABEYSGXPBTA-RXSVEWSESA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;phosphoric acid Chemical compound OP(O)(O)=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O DBSABEYSGXPBTA-RXSVEWSESA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- UUGLSEIATNSHRI-UHFFFAOYSA-N 1,3,4,6-tetrakis(hydroxymethyl)-3a,6a-dihydroimidazo[4,5-d]imidazole-2,5-dione Chemical compound OCN1C(=O)N(CO)C2C1N(CO)C(=O)N2CO UUGLSEIATNSHRI-UHFFFAOYSA-N 0.000 description 1
- RSWGJHLUYNHPMX-UHFFFAOYSA-N 1,4a-dimethyl-7-propan-2-yl-2,3,4,4b,5,6,10,10a-octahydrophenanthrene-1-carboxylic acid Chemical compound C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 description 1
- OOWQBDFWEXAXPB-IBGZPJMESA-N 1-O-hexadecyl-sn-glycerol Chemical compound CCCCCCCCCCCCCCCCOC[C@@H](O)CO OOWQBDFWEXAXPB-IBGZPJMESA-N 0.000 description 1
- LALVCWMSKLEQMK-UHFFFAOYSA-N 1-phenyl-3-(4-propan-2-ylphenyl)propane-1,3-dione Chemical compound C1=CC(C(C)C)=CC=C1C(=O)CC(=O)C1=CC=CC=C1 LALVCWMSKLEQMK-UHFFFAOYSA-N 0.000 description 1
- MEZZCSHVIGVWFI-UHFFFAOYSA-N 2,2'-Dihydroxy-4-methoxybenzophenone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1O MEZZCSHVIGVWFI-UHFFFAOYSA-N 0.000 description 1
- NSISNUCBIDVASV-UHFFFAOYSA-N 2-(2-ethylhexoxycarbonyl)-3-(4-methoxyphenyl)prop-2-enoic acid Chemical compound CCCCC(CC)COC(=O)C(C(O)=O)=CC1=CC=C(OC)C=C1 NSISNUCBIDVASV-UHFFFAOYSA-N 0.000 description 1
- QBXAOVITMNMUHV-UHFFFAOYSA-N 2-[[2-hydroxy-2-(hydroxymethyl)octadecoxy]methyl]octadecane-1,2-diol Chemical compound CCCCCCCCCCCCCCCCC(O)(CO)COCC(O)(CO)CCCCCCCCCCCCCCCC QBXAOVITMNMUHV-UHFFFAOYSA-N 0.000 description 1
- KXTAOXNYQGASTA-UHFFFAOYSA-N 2-benzylidenepropanedioic acid Chemical compound OC(=O)C(C(O)=O)=CC1=CC=CC=C1 KXTAOXNYQGASTA-UHFFFAOYSA-N 0.000 description 1
- KUNNUNBSGQSGDY-UHFFFAOYSA-N 2-butyl-6-methylphenol Chemical compound CCCCC1=CC=CC(C)=C1O KUNNUNBSGQSGDY-UHFFFAOYSA-N 0.000 description 1
- NPSJHQMIVNJLNN-UHFFFAOYSA-N 2-ethylhexyl 4-nitrobenzoate Chemical compound CCCCC(CC)COC(=O)C1=CC=C([N+]([O-])=O)C=C1 NPSJHQMIVNJLNN-UHFFFAOYSA-N 0.000 description 1
- 239000004808 2-ethylhexylester Substances 0.000 description 1
- VHBSECWYEFJRNV-UHFFFAOYSA-N 2-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=CC=C1O.OC(=O)C1=CC=CC=C1O VHBSECWYEFJRNV-UHFFFAOYSA-N 0.000 description 1
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 description 1
- ODJQKYXPKWQWNK-UHFFFAOYSA-N 3,3'-Thiobispropanoic acid Chemical compound OC(=O)CCSCCC(O)=O ODJQKYXPKWQWNK-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- NRWMBHYHFFGEEC-MDZDMXLPSA-N 3-[(e)-octadec-9-enoxy]propane-1,2-diol Chemical compound CCCCCCCC\C=C\CCCCCCCCOCC(O)CO NRWMBHYHFFGEEC-MDZDMXLPSA-N 0.000 description 1
- QJZYHAIUNVAGQP-UHFFFAOYSA-N 3-nitrobicyclo[2.2.1]hept-5-ene-2,3-dicarboxylic acid Chemical compound C1C2C=CC1C(C(=O)O)C2(C(O)=O)[N+]([O-])=O QJZYHAIUNVAGQP-UHFFFAOYSA-N 0.000 description 1
- MRBKEAMVRSLQPH-UHFFFAOYSA-N 3-tert-butyl-4-hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1 MRBKEAMVRSLQPH-UHFFFAOYSA-N 0.000 description 1
- GWXXFGWOWOJEEX-UHFFFAOYSA-N 4,4,4-trihydroxy-1-phenylbutan-1-one Chemical compound OC(CCC(=O)C1=CC=CC=C1)(O)O GWXXFGWOWOJEEX-UHFFFAOYSA-N 0.000 description 1
- KKJKXQYVUVWWJP-UHFFFAOYSA-N 4-[(4,7,7-trimethyl-3-oxo-2-bicyclo[2.2.1]heptanylidene)methyl]benzenesulfonic acid Chemical compound CC1(C)C2CCC1(C)C(=O)C2=CC1=CC=C(S(O)(=O)=O)C=C1 KKJKXQYVUVWWJP-UHFFFAOYSA-N 0.000 description 1
- ALYNCZNDIQEVRV-PZFLKRBQSA-N 4-amino-3,5-ditritiobenzoic acid Chemical compound [3H]c1cc(cc([3H])c1N)C(O)=O ALYNCZNDIQEVRV-PZFLKRBQSA-N 0.000 description 1
- 125000002528 4-isopropyl benzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])*)C([H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- RDDUUHBRMWYBJX-UHFFFAOYSA-N 4-oct-1-enoxy-4-oxobutanoic acid Chemical compound CCCCCCC=COC(=O)CCC(O)=O RDDUUHBRMWYBJX-UHFFFAOYSA-N 0.000 description 1
- BSYNRYMUTXBXSQ-FOQJRBATSA-N 59096-14-9 Chemical compound CC(=O)OC1=CC=CC=C1[14C](O)=O BSYNRYMUTXBXSQ-FOQJRBATSA-N 0.000 description 1
- PGLFPEYYIQQJOP-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O.NCCCCCC(O)=O PGLFPEYYIQQJOP-UHFFFAOYSA-N 0.000 description 1
- YLIIGKBLXUJUIG-UHFFFAOYSA-N 7-hexylazepan-2-one Chemical compound CCCCCCC1CCCCC(=O)N1 YLIIGKBLXUJUIG-UHFFFAOYSA-N 0.000 description 1
- 229910002012 Aerosil® Inorganic materials 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 235000019890 Amylum Nutrition 0.000 description 1
- 229930003347 Atropine Natural products 0.000 description 1
- XHVAWZZCDCWGBK-WYRLRVFGSA-M Aurothioglucose Chemical compound OC[C@H]1O[C@H](S[Au])[C@H](O)[C@@H](O)[C@@H]1O XHVAWZZCDCWGBK-WYRLRVFGSA-M 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- GWZYPXHJIZCRAJ-UHFFFAOYSA-N Biliverdin Natural products CC1=C(C=C)C(=C/C2=NC(=Cc3[nH]c(C=C/4NC(=O)C(=C4C)C=C)c(C)c3CCC(=O)O)C(=C2C)CCC(=O)O)NC1=O GWZYPXHJIZCRAJ-UHFFFAOYSA-N 0.000 description 1
- RCNSAJSGRJSBKK-NSQVQWHSSA-N Biliverdin IX Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(\C=C/2C(=C(C)C(=C/C=3C(=C(C=C)C(=O)N=3)C)/N\2)CCC(O)=O)N1 RCNSAJSGRJSBKK-NSQVQWHSSA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- XMJBQVVHFQDVJO-UHFFFAOYSA-N C(CCCCCCCC=CCCCCCCCC)C(COCC(O)(CO)CCCCCCCCC=CCCCCCCCC)(O)CO Chemical compound C(CCCCCCCC=CCCCCCCCC)C(COCC(O)(CO)CCCCCCCCC=CCCCCCCCC)(O)CO XMJBQVVHFQDVJO-UHFFFAOYSA-N 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- 208000003643 Callosities Diseases 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229910052684 Cerium Inorganic materials 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- LAAPRQODJPXAHC-UHFFFAOYSA-N Coniferyl benzoate Natural products C1=C(O)C(OC)=CC(C=CCOC(=O)C=2C=CC=CC=2)=C1 LAAPRQODJPXAHC-UHFFFAOYSA-N 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 206010012434 Dermatitis allergic Diseases 0.000 description 1
- GHKOFFNLGXMVNJ-UHFFFAOYSA-N Didodecyl thiobispropanoate Chemical compound CCCCCCCCCCCCOC(=O)CCSCCC(=O)OCCCCCCCCCCCC GHKOFFNLGXMVNJ-UHFFFAOYSA-N 0.000 description 1
- 239000003508 Dilauryl thiodipropionate Substances 0.000 description 1
- 239000002656 Distearyl thiodipropionate Substances 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- FMRHJJZUHUTGKE-UHFFFAOYSA-N Ethylhexyl salicylate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1O FMRHJJZUHUTGKE-UHFFFAOYSA-N 0.000 description 1
- 241000173371 Garcinia indica Species 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 102100029360 Hematopoietic cell signal transducer Human genes 0.000 description 1
- 101000990188 Homo sapiens Hematopoietic cell signal transducer Proteins 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- RKUNBYITZUJHSG-UHFFFAOYSA-N Hyosciamin-hydrochlorid Natural products CN1C(C2)CCC1CC2OC(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010061217 Infestation Diseases 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- SHGAZHPCJJPHSC-NUEINMDLSA-N Isotretinoin Chemical compound OC(=O)C=C(C)/C=C/C=C(C)C=CC1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-NUEINMDLSA-N 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- JHWNWJKBPDFINM-UHFFFAOYSA-N Laurolactam Chemical compound O=C1CCCCCCCCCCCN1 JHWNWJKBPDFINM-UHFFFAOYSA-N 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- CQOVPNPJLQNMDC-UHFFFAOYSA-N N-beta-alanyl-L-histidine Natural products NCCC(=O)NC(C(O)=O)CC1=CN=CN1 CQOVPNPJLQNMDC-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- WYWZRNAHINYAEF-UHFFFAOYSA-N Padimate O Chemical compound CCCCC(CC)COC(=O)C1=CC=C(N(C)C)C=C1 WYWZRNAHINYAEF-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- KNAHARQHSZJURB-UHFFFAOYSA-N Propylthiouracile Chemical compound CCCC1=CC(=O)NC(=S)N1 KNAHARQHSZJURB-UHFFFAOYSA-N 0.000 description 1
- 206010037888 Rash pustular Diseases 0.000 description 1
- VYGQUTWHTHXGQB-UHFFFAOYSA-N Retinol hexadecanoate Natural products CCCCCCCCCCCCCCCC(=O)OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-UHFFFAOYSA-N 0.000 description 1
- 235000001537 Ribes X gardonianum Nutrition 0.000 description 1
- 235000001535 Ribes X utile Nutrition 0.000 description 1
- 235000016919 Ribes petraeum Nutrition 0.000 description 1
- 244000281247 Ribes rubrum Species 0.000 description 1
- 235000002355 Ribes spicatum Nutrition 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- ARCJQKUWGAZPFX-KBPBESRZSA-N S-trans-stilbene oxide Chemical compound C1([C@H]2[C@@H](O2)C=2C=CC=CC=2)=CC=CC=C1 ARCJQKUWGAZPFX-KBPBESRZSA-N 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- RJFAYQIBOAGBLC-BYPYZUCNSA-N Selenium-L-methionine Chemical compound C[Se]CC[C@H](N)C(O)=O RJFAYQIBOAGBLC-BYPYZUCNSA-N 0.000 description 1
- RJFAYQIBOAGBLC-UHFFFAOYSA-N Selenomethionine Natural products C[Se]CCC(N)C(O)=O RJFAYQIBOAGBLC-UHFFFAOYSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000003490 Thiodipropionic acid Substances 0.000 description 1
- 102000002933 Thioredoxin Human genes 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 229920004482 WACKER® Polymers 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 description 1
- RLZLDSDDRORMOV-DBQHITQZSA-M [Na+].Cl.COc1ccc2cc(ccc2c1)[C@H](C)C([O-])=O.CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC Chemical compound [Na+].Cl.COc1ccc2cc(ccc2c1)[C@H](C)C([O-])=O.CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC RLZLDSDDRORMOV-DBQHITQZSA-M 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 229960002916 adapalene Drugs 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- 150000004347 all-trans-retinol derivatives Chemical class 0.000 description 1
- 230000002009 allergenic effect Effects 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 229940061720 alpha hydroxy acid Drugs 0.000 description 1
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 1
- 239000011795 alpha-carotene Substances 0.000 description 1
- 235000003903 alpha-carotene Nutrition 0.000 description 1
- ANVAOWXLWRTKGA-HLLMEWEMSA-N alpha-carotene Natural products C(=C\C=C\C=C(/C=C/C=C(\C=C\C=1C(C)(C)CCCC=1C)/C)\C)(\C=C\C=C(/C=C/[C@H]1C(C)=CCCC1(C)C)\C)/C ANVAOWXLWRTKGA-HLLMEWEMSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- CEGOLXSVJUTHNZ-UHFFFAOYSA-K aluminium tristearate Chemical compound [Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CEGOLXSVJUTHNZ-UHFFFAOYSA-K 0.000 description 1
- 229940099583 aluminum starch octenylsuccinate Drugs 0.000 description 1
- 229940063655 aluminum stearate Drugs 0.000 description 1
- UBNYRXMKIIGMKK-UHFFFAOYSA-N amiloxate Chemical compound COC1=CC=C(C=CC(=O)OCCC(C)C)C=C1 UBNYRXMKIIGMKK-UHFFFAOYSA-N 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000012874 anionic emulsifier Substances 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 239000000058 anti acne agent Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940124340 antiacne agent Drugs 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 125000003289 ascorbyl group Chemical group [H]O[C@@]([H])(C([H])([H])O*)[C@@]1([H])OC(=O)C(O*)=C1O* 0.000 description 1
- 229940071097 ascorbyl phosphate Drugs 0.000 description 1
- 239000010426 asphalt Substances 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- RKUNBYITZUJHSG-SPUOUPEWSA-N atropine Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)N2C)C(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-SPUOUPEWSA-N 0.000 description 1
- 229960000396 atropine Drugs 0.000 description 1
- 229960001799 aurothioglucose Drugs 0.000 description 1
- XNEFYCZVKIDDMS-UHFFFAOYSA-N avobenzone Chemical compound C1=CC(OC)=CC=C1C(=O)CC(=O)C1=CC=C(C(C)(C)C)C=C1 XNEFYCZVKIDDMS-UHFFFAOYSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- IWWCATWBROCMCW-UHFFFAOYSA-N batyl alcohol Natural products CCCCCCCCCCCCCCCCCCOC(O)CO IWWCATWBROCMCW-UHFFFAOYSA-N 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid group Chemical group C(C1=CC=CC=C1)(=O)O WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- 150000008366 benzophenones Chemical class 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- QBUVFDKTZJNUPP-UHFFFAOYSA-N biliverdin-IXalpha Natural products N1C(=O)C(C)=C(C=C)C1=CC1=C(C)C(CCC(O)=O)=C(C=C2C(=C(C)C(C=C3C(=C(C=C)C(=O)N3)C)=N2)CCC(O)=O)N1 QBUVFDKTZJNUPP-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036765 blood level Effects 0.000 description 1
- 235000021324 borage oil Nutrition 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- VNSBYDPZHCQWNB-UHFFFAOYSA-N calcium;aluminum;dioxido(oxo)silane;sodium;hydrate Chemical compound O.[Na].[Al].[Ca+2].[O-][Si]([O-])=O VNSBYDPZHCQWNB-UHFFFAOYSA-N 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 230000001364 causal effect Effects 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- 150000001783 ceramides Chemical class 0.000 description 1
- ZMIGMASIKSOYAM-UHFFFAOYSA-N cerium Chemical compound [Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce] ZMIGMASIKSOYAM-UHFFFAOYSA-N 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 125000003636 chemical group Chemical group 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- OOWQBDFWEXAXPB-UHFFFAOYSA-N chimyl alcohol Natural products CCCCCCCCCCCCCCCCOCC(O)CO OOWQBDFWEXAXPB-UHFFFAOYSA-N 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol group Chemical group [C@@H]1(CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)[C@H](C)CCCC(C)C HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 239000010634 clove oil Substances 0.000 description 1
- 239000003026 cod liver oil Substances 0.000 description 1
- 235000012716 cod liver oil Nutrition 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- LAAPRQODJPXAHC-AATRIKPKSA-N coniferyl benzoate Chemical compound C1=C(O)C(OC)=CC(\C=C\COC(=O)C=2C=CC=CC=2)=C1 LAAPRQODJPXAHC-AATRIKPKSA-N 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 230000006003 cornification Effects 0.000 description 1
- FZCHYNWYXKICIO-FZNHGJLXSA-N cortisol 17-valerate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)CO)(OC(=O)CCCC)[C@@]1(C)C[C@@H]2O FZCHYNWYXKICIO-FZNHGJLXSA-N 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- OOTFVKOQINZBBF-UHFFFAOYSA-N cystamine Chemical compound CCSSCCN OOTFVKOQINZBBF-UHFFFAOYSA-N 0.000 description 1
- 229940099500 cystamine Drugs 0.000 description 1
- 229960002433 cysteine Drugs 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 description 1
- NZZIMKJIVMHWJC-UHFFFAOYSA-N dibenzoylmethane Chemical class C=1C=CC=CC=1C(=O)CC(=O)C1=CC=CC=C1 NZZIMKJIVMHWJC-UHFFFAOYSA-N 0.000 description 1
- 235000019304 dilauryl thiodipropionate Nutrition 0.000 description 1
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 1
- PWWSSIYVTQUJQQ-UHFFFAOYSA-N distearyl thiodipropionate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)CCSCCC(=O)OCCCCCCCCCCCCCCCCCC PWWSSIYVTQUJQQ-UHFFFAOYSA-N 0.000 description 1
- 235000019305 distearyl thiodipropionate Nutrition 0.000 description 1
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 1
- 229940090949 docosahexaenoic acid Drugs 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- HEAHZSUCFKFERC-UHFFFAOYSA-N ecamsule Chemical compound CC1(C)C2CCC1(CS(O)(=O)=O)C(=O)C2=CC(C=C1)=CC=C1C=C1C(=O)C2(CS(O)(=O)=O)CCC1C2(C)C HEAHZSUCFKFERC-UHFFFAOYSA-N 0.000 description 1
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 1
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 1
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 1
- OYFJQPXVCSSHAI-QFPUQLAESA-N enalapril maleate Chemical compound OC(=O)\C=C/C(O)=O.C([C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(O)=O)CC1=CC=CC=C1 OYFJQPXVCSSHAI-QFPUQLAESA-N 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Chemical group CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 1
- 235000008524 evening primrose extract Nutrition 0.000 description 1
- 229940089020 evening primrose oil Drugs 0.000 description 1
- 239000010475 evening primrose oil Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 229940043259 farnesol Drugs 0.000 description 1
- 229930002886 farnesol Natural products 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 229940013317 fish oils Drugs 0.000 description 1
- 239000004872 foam stabilizing agent Substances 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000021588 free fatty acids Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 125000005908 glyceryl ester group Chemical group 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 125000003147 glycosyl group Chemical group 0.000 description 1
- 239000003163 gonadal steroid hormone Substances 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- KWLMIXQRALPRBC-UHFFFAOYSA-L hectorite Chemical compound [Li+].[OH-].[OH-].[Na+].[Mg+2].O1[Si]2([O-])O[Si]1([O-])O[Si]([O-])(O1)O[Si]1([O-])O2 KWLMIXQRALPRBC-UHFFFAOYSA-L 0.000 description 1
- 229910000271 hectorite Inorganic materials 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 239000004021 humic acid Substances 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 229920001600 hydrophobic polymer Polymers 0.000 description 1
- 230000005661 hydrophobic surface Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 150000002460 imidazoles Chemical class 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000008384 inner phase Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229910000358 iron sulfate Inorganic materials 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 229960005280 isotretinoin Drugs 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 229910052622 kaolinite Inorganic materials 0.000 description 1
- 150000003951 lactams Chemical class 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- AGBQKNBQESQNJD-UHFFFAOYSA-M lipoate Chemical compound [O-]C(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-M 0.000 description 1
- 235000019136 lipoic acid Nutrition 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- HCWCAKKEBCNQJP-UHFFFAOYSA-N magnesium orthosilicate Chemical compound [Mg+2].[Mg+2].[O-][Si]([O-])([O-])[O-] HCWCAKKEBCNQJP-UHFFFAOYSA-N 0.000 description 1
- 235000019792 magnesium silicate Nutrition 0.000 description 1
- 229910052919 magnesium silicate Inorganic materials 0.000 description 1
- 235000012243 magnesium silicates Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 229960005479 mesulfen Drugs 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- MJVGBKJNTFCUJM-UHFFFAOYSA-N mexenone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=C(C)C=C1 MJVGBKJNTFCUJM-UHFFFAOYSA-N 0.000 description 1
- 229960002509 miconazole Drugs 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229910052901 montmorillonite Inorganic materials 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- WPBWJEYRHXACLR-UHFFFAOYSA-N nonanedioic acid Chemical compound OC(=O)CCCCCCCC(O)=O.OC(=O)CCCCCCCC(O)=O WPBWJEYRHXACLR-UHFFFAOYSA-N 0.000 description 1
- 229910000273 nontronite Inorganic materials 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- YBGZDTIWKVFICR-UHFFFAOYSA-N octinoxate Chemical compound CCCCC(CC)COC(=O)C=CC1=CC=C(OC)C=C1 YBGZDTIWKVFICR-UHFFFAOYSA-N 0.000 description 1
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical group C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 description 1
- 229960000601 octocrylene Drugs 0.000 description 1
- 229960002969 oleic acid Drugs 0.000 description 1
- 125000001117 oleyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- SOQBVABWOPYFQZ-UHFFFAOYSA-N oxygen(2-);titanium(4+) Chemical class [O-2].[O-2].[Ti+4] SOQBVABWOPYFQZ-UHFFFAOYSA-N 0.000 description 1
- 229940094443 oxytocics prostaglandins Drugs 0.000 description 1
- 125000001312 palmitoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 229920000933 poly (ε-caprolactam) Polymers 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000223 polyglycerol Polymers 0.000 description 1
- 229920000193 polymethacrylate Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229960002662 propylthiouracil Drugs 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 208000029561 pustule Diseases 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- WBHHMMIMDMUBKC-XLNAKTSKSA-N ricinelaidic acid Chemical class CCCCCC[C@@H](O)C\C=C\CCCCCCCC(O)=O WBHHMMIMDMUBKC-XLNAKTSKSA-N 0.000 description 1
- 229960003656 ricinoleic acid Drugs 0.000 description 1
- FEUQNCSVHBHROZ-UHFFFAOYSA-N ricinoleic acid Natural products CCCCCCC(O[Si](C)(C)C)CC=CCCCCCCCC(=O)OC FEUQNCSVHBHROZ-UHFFFAOYSA-N 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 229910000275 saponite Inorganic materials 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- NRWMBHYHFFGEEC-UHFFFAOYSA-N selachyl alcohol Natural products CCCCCCCCC=CCCCCCCCCOCC(O)CO NRWMBHYHFFGEEC-UHFFFAOYSA-N 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229960002718 selenomethionine Drugs 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000003079 shale oil Substances 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- 239000010454 slate Substances 0.000 description 1
- 229910021647 smectite Inorganic materials 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 229940080313 sodium starch Drugs 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 239000004071 soot Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- ARCJQKUWGAZPFX-UHFFFAOYSA-N stilbene oxide Chemical compound O1C(C=2C=CC=CC=2)C1C1=CC=CC=C1 ARCJQKUWGAZPFX-UHFFFAOYSA-N 0.000 description 1
- 235000021286 stilbenes Nutrition 0.000 description 1
- 150000001629 stilbenes Chemical class 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 150000003458 sulfonic acid derivatives Chemical class 0.000 description 1
- 150000003460 sulfonic acids Chemical class 0.000 description 1
- 125000005555 sulfoximide group Chemical group 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 239000011275 tar sand Substances 0.000 description 1
- LITQZINTSYBKIU-UHFFFAOYSA-F tetracopper;hexahydroxide;sulfate Chemical compound [OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Cu+2].[Cu+2].[Cu+2].[Cu+2].[O-]S([O-])(=O)=O LITQZINTSYBKIU-UHFFFAOYSA-F 0.000 description 1
- 229960002663 thioctic acid Drugs 0.000 description 1
- 235000019303 thiodipropionic acid Nutrition 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- 229940094937 thioredoxin Drugs 0.000 description 1
- 108060008226 thioredoxin Proteins 0.000 description 1
- 239000010678 thyme oil Substances 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 125000002640 tocopherol group Chemical class 0.000 description 1
- 235000019149 tocopherols Nutrition 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- LOIYMIARKYCTBW-OWOJBTEDSA-N trans-urocanic acid Chemical compound OC(=O)\C=C\C1=CNC=N1 LOIYMIARKYCTBW-OWOJBTEDSA-N 0.000 description 1
- LOIYMIARKYCTBW-UHFFFAOYSA-N trans-urocanic acid Natural products OC(=O)C=CC1=CNC=N1 LOIYMIARKYCTBW-UHFFFAOYSA-N 0.000 description 1
- ICUTUKXCWQYESQ-UHFFFAOYSA-N triclocarban Chemical compound C1=CC(Cl)=CC=C1NC(=O)NC1=CC=C(Cl)C(Cl)=C1 ICUTUKXCWQYESQ-UHFFFAOYSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-O triethanolammonium Chemical class OCC[NH+](CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-O 0.000 description 1
- 239000001069 triethyl citrate Substances 0.000 description 1
- 235000013769 triethyl citrate Nutrition 0.000 description 1
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- RNWHGQJWIACOKP-UHFFFAOYSA-N zinc;oxygen(2-) Chemical compound [O-2].[Zn+2] RNWHGQJWIACOKP-UHFFFAOYSA-N 0.000 description 1
- 229910052726 zirconium Inorganic materials 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0241—Containing particulates characterized by their shape and/or structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/27—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/29—Titanium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8152—Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/88—Polyamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/30—Characterized by the absence of a particular group of ingredients
- A61K2800/33—Free of surfactant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/60—Particulates further characterized by their structure or composition
- A61K2800/65—Characterized by the composition of the particulate/core
- A61K2800/654—The particulate/core comprising macromolecular material
Definitions
- the present invention relates to emulsifier-free finely dispersed systems of the oil-in-water and water-in-oil type, preferably as cosmetic or dermatological preparations.
- Emulsions are generally understood to mean heterogeneous systems which consist of two liquids which are immiscible or only miscible with one another to a limited extent and are usually referred to as phases.
- one of the two liquids is dispersed in the other liquid in the form of very fine droplets.
- the two liquids are water and oil and oil droplets are finely distributed in water, it is an oil-in-water emulsion (O / W emulsion, e.g. milk).
- O / W emulsion oil-in-water emulsion
- the basic character of an O ⁇ / V emulsion is characterized by the water.
- a water-in-oil emulsion (W / O emulsion, e.g. butter) is the opposite principle, whereby the basic character is determined by the oil.
- Emulsifiers In order to achieve permanent dispersion of one liquid in another, the addition of a surface-active substance (emulsifier) is necessary for emulsions in the conventional sense.
- Emulsifiers have an amphiphilic molecular structure consisting of a polar (hydrophilic) and a non-polar (lipophilic) part of the molecule, which are spatially separated from each other.
- emulsifiers In simple emulsions there are finely dispersed droplets of the second phase (water droplets in W / O or lipid vesicles in O / W emulsions) enclosed in an emulsifier shell.
- Emulsifiers reduce the interfacial tension between the phases by being located at the interface between the two liquids. They form at the live exclude oil / water interface films, which counteracts the irreversible confluence of the droplets. Mixtures of emulsifiers are often used to stabilize emulsions.
- emulsifiers can be divided into ionic (anionic, cationic and amphoteric) and nonionic according to their hydrophilic part of the molecule:.
- anionic emulsifier is soap, which is commonly referred to as the water-soluble sodium or potassium salts of the saturated and unsaturated higher fatty acids.
- the quaternary ammonium compounds are important representatives of the cationic emulsifiers.
- the hydrophilic part of the molecule of nonionic emulsifiers often consists of glycerol, polyglycerol, sorbitan, carbohydrates or polyoxyethylene glycols and is usually linked to the lipophilic part of the molecule via ester and ether bonds. This usually consists of fatty alcohols, fatty acids or isofatty acids.
- lipophilicity and hydrophilicity of emulsifiers can be changed within wide limits.
- emulsifiers The correct choice of emulsifiers is decisive for the stability of an emulsion. The characteristics of all substances contained in the system must be taken into account. Looking at z. B. skin care emulsions, polar oil components and, for example, UV filters lead to instabilities. In addition to the emulsifiers, other stabilizers are therefore used which, for example, increase the viscosity of the emulsion and / or act as a protective colloid.
- Emulsions are an important product type in the field of cosmetic and / or dermatological preparations.
- Cosmetic preparations are mainly used for skin care.
- Skin care in the cosmetic sense is primarily that the natural function of the skin as a barrier against environmental influences (eg dirt, chemicals, microorganisms) and against the loss of the body's own substances (eg water, natural fats, electrolytes) is strengthened or restored. If this function is disturbed, it can lead to stronger absorption of toxic or allergenic substances or infestation of microorganisms and, as a result, toxic or allergic skin reactions.
- the aim of skin care is also to compensate for the loss of fat and water in the skin caused by daily washing. This is especially important when the natural regeneration ability is insufficient.
- skin care products are intended to protect against environmental influences, especially sun and wind, and to delay skin aging.
- Cosmetic preparations are also used as deodorants. Such formulations serve to eliminate body odor that arises when the odorless fresh sweat is decomposed by microorganisms.
- Medical topical compositions usually contain one or more drugs in effective concentration.
- drugs for the sake of simplicity, reference is made to the legal provisions of the Federal Republic of Germany for a clear distinction between cosmetic and medical use and corresponding products (e.g. cosmetics ordinance, food and drug law).
- emulsifiers like any chemical substance, can cause allergic or hypersensitive reactions in individual cases.
- a reduction in the amount of emulsifier required can, for. B. can be achieved if it is used that finely divided solid particles have an additional stabilizing effect.
- the solid material accumulates at the oil / water phase boundary in the form of a layer, which causes the disperse phases to flow together. is prevented. It is not the chemical, but the surface properties of the solid particles that are essential.
- the solid particles are only suitable for stabilization if they are significantly smaller than the droplets of the inner phase and do not tend to form agglomerates.
- Another important property of an emulsion-stabilizing solid is its wettability. That To stabilize an O ⁇ / emulsion, the solid must, for example, be wettable more easily by water than by oil.
- European laid-open specification 0 686 391 describes water-in-oil emulsions which are free of surface-active substances and are only stabilized by solids. Spherical polyalkylsilsesquioxane particles with a diameter of 100 nm to 20 ⁇ m are used for stabilization. These emulsions can be referred to as Pickering emulsions after the above.
- Hydrodispersions are dispersions of a liquid, semisolid or solid inner (discontinuous) lipid phase in an outer aqueous (continuous) phase.
- the stability can be ensured, for example, by building a gel structure in the aqueous phase in which the lipid droplets are stably suspended.
- German Offenlegungsschrift 44 25 268 describes stable, finely dispersed, emulsifier-free cosmetic or dermatological preparations of the oil-in-water type which, in addition to an oil and a water phase, contain one or more thickeners from the group of acrylic acid polymers, polysaccharides and their alkyl ethers, and for these Thickener an interfacial tension reduction must not be measurable.
- German Offenlegungsschrift 43 03 983 discloses cosmetic or dermatological light protection formulations which are essentially free from emulsifiers, the hydrochloride being inorganic micropigments are incorporated, which serve as UV filter substances.
- the object of the present invention was to enrich the prior art with cosmetic or dermatological preparations, in which any use of conventional emulsifiers can be dispensed with.
- cosmetic or dermatological preparations which are finely dispersed systems of the oil-in-water or water-in-oil type
- the preparations contain significantly less than 0.5% by weight of one or more emulsifiers or are even completely emulsifier-free.
- the preparations according to the invention are mixtures of oils or oil-soluble substances and water or water-soluble components which are stabilized by the addition of the microfine polymer particles and do not have to contain an emulsifier in the conventional sense.
- the stabilization is achieved in that the microfine polymer particles attach to the droplets of the disperse phase and form, so to speak, a mechanical barrier that prevents the coalescing, ie the confluence of the droplets.
- the preparations according to the invention are extremely satisfactory preparations in every respect, which are surprisingly highly variable in their water-fat phase ratio and also offer the advantage over the prior art that large amounts of oils can be incorporated stably in water. It was also surprising that if the teaching on technical action disclosed herewith is followed, both Pickering emulsions of the water-in-oil type and Pickering emulsions of the oil-in-water type can be produced.
- Advantageous microfine polymer particles for the purposes of the present invention are, for example, polycarbonates, polyethers, polyethylene, polypropylene, polyvinyl chloride, polystyrene, polyamides, polyacrylates and the like.
- microfine polyamide particles which are available under the trade name SP-500 from TORAY are advantageous.
- Polyamide 6 also: nylon 6) or polyamide 12 (also: nylon 12) particles are also advantageous.
- Polyamide 6 is the polyamide [poly ( ⁇ -caprolactam)] composed of ⁇ -aminocaproic acid (6-aminohexanoic acid) or ⁇ -caprolactam
- polyamide 12 is a poly ( ⁇ -lauric lactam) made of ⁇ -laurolactam.
- Advantageous for the purposes of the present invention are, for example Orgasol ® 1002 (polyamide 6) and Orgasol ® 2002 (polyamide 12) from ELF ATOCHEM.
- Microfine polymethacrylates are further advantageous polymer particles.
- Such particles are available, for example, under the trade name POLYTRAP ® from DOW CHEMICAL.
- microfine polymer particles used are coated on the surface.
- This surface treatment can consist in that the pigments are provided with a thin hydrophilic layer by methods known per se.
- Advantageous coatings consist, for example, of TiO 2 , ZrO 2 or other polymers, such as polymethyl methacrylate.
- Particularly advantageous microfine polymer particles for the purposes of the present invention are also obtainable by the process for the hydrophilic coating of hydrophobic polymer particles described in US Pat. No. 4,898,913.
- the average particle diameter of the microfine polymer particles used is less than 100 ⁇ m, particularly advantageously less than 50 ⁇ m. It is essentially irrelevant in which form (platelets, rods, beads, etc.) the polymer particles used are present.
- amphiphilic, microfine polymer particles according to the invention with further amphiphilic pigments, which may also contribute to stabilizing the Pickering emulsions.
- Such pigments are, for example, micronized, inorganic pigments which are selected from the group of amphiphilic metal oxides, in particular from the group titanium dioxide, zinc oxide, silicon dioxide or silicates (for example talcum), where the metal oxides can be present either individually or in a mixture . It is essentially irrelevant in which of the possibly naturally occurring modifications the amphiphilic metal oxides used are present.
- the average particle diameter of the amphiphilic metal oxides used for combination with polymer particles according to the invention is preferably selected between 1 nm and 200 nm, particularly advantageously between 5 nm and 100 nm.
- amphiphilic microfine polymer particles according to the invention with untreated, almost pure, amphiphilic metal oxide particles, in particular with those which are also used as a dye in the food industry and / or as an absorber of UV radiation in sunscreen agents can be.
- Advantageous are, for example, the zinc oxide pigments available from Merck and those that are available under the trade names zinc oxide neutral from Haarmann & Reimer or NanoX from the Harcros Chemical Group.
- Another advantageous, untreated pigment is boron nitride.
- the microfine polymer particle or particles are preferably combined with the boron nitrides listed below:
- the average particle diameter of the boron nitride particles used is preferably chosen to be less than 20 ⁇ m, in particular less than 15 ⁇ m.
- Also advantageous according to the invention is the combination of microfine polymer particles with amphiphilic inorganic pigments which have been surface-treated ("coated") in a water-repellent manner, and at the same time an amphiphilic character of these pigments is to be formed or maintained.
- This surface treatment can consist in that the Pigments are provided with a thin hydrophobic layer by methods known per se.
- One such method which is described below using the example of titanium dioxide, consists, for example, in that the hydrophobic surface layer after a reaction according to
- n and m are stoichiometric parameters to be used at will, R and R 'are the desired organic radicals.
- Particularly advantageous combination partners are TiO 2 pigments, for example those coated with aluminum stearate, available under the trade name MT 100 T from TAYCA.
- Another advantageous coating of the combination partners consists of dimethylpolysiloxane (also: Dimethicone), a mixture of fully methylated, linear siloxane polymers which are blocked at the end with trimethylsiloxy units.
- the combination of microfine polymer particles with zinc oxide pigments, which are coated in this way, is particularly advantageous in the sense of the present invention.
- Advantageous combination partners are also available from Carborundum under the trade name Tres BN ® UHP 1106, boron nitride particles treated with dimethicone.
- coated boron nitride particles are also those which have been treated with polymethylhydrogensiloxane, a linear polysiloxane, which is also referred to as methicone.
- Advantageous boron nitride particles treated with methicone are, for example, those available from Carborundum under the trade name Tres BN® UHP 1107.
- the inorganic amphiphilic pigments used in addition to microfine polymer particles are coated with a mixture of dimethylpolysiloxane, in particular dimethylpolysiloxane with an average chain length of 200 to 350 dimethylsiloxane units, and silica gel, which is also referred to as simethicone.
- the inorganic pigments are additionally coated with aluminum hydroxide or aluminum oxide hydrate (also: alumina, CAS no .: 1333-84-2).
- Particularly advantageous combination partners are titanium dioxides which are coated with simethicone and alumina, the coating also being able to contain water.
- An example of this is the titanium dioxide available from Merck under the trade name Eusolex T2000.
- Another advantage of the present invention is the combination of microfine polymer particles with a mixture of different inorganic, amphiphilic pigment types both within a crystal, for example as iron mixed oxide or talc (magnesium silicate), as well as by mixing several metal oxide types within one preparation.
- Particularly advantageous combination partners are magnesium silicates, for example those available from Grolmann under the trade name Talkum Micron.
- the amphiphilic microfine polymer particles according to the invention can furthermore advantageously be combined with other pigments, for example with titanium dioxide pigments which are coated with octylsilanol, and / or with silicon dioxide particles which have been treated to be water-repellent on the surface.
- Silicon dioxide particles suitable for combination are, for example, spherical polyalkylsilsesquioxane particles as mentioned in European laid-open specification 0 686 391. Such polyalkylsilsesquioxane particles are available, for example, from Degussa under the trade names Aerosil R972 and Aerosil 200V.
- amphiphilic microfine polymer particles according to the invention are furthermore preferably combined with amphiphilic modified polysaccharides which do not show any thickening properties.
- amphiphilic polysaccharides can be obtained, for example, by reacting starch with mono-, bi- or polyfunctional reagents or oxidizing agents in reactions which are largely polymer-analogous.
- R can represent, for example, a hydrogen and / or an alkyl and / or aralkyl radical (in the case of starch ethers) or a hydrogen and / or an organic and / or inorganic acid radical (in the case of starch esters).
- Starch ethers and starch esters are advantageous combination partners in the sense of the present invention. It is particularly advantageous to combine the polymer particles of the invention with starch ethers, e.g. B. with those which are obtainable by etherification of starch with tetramethylolacetylene diurea and which are referred to as Amylum non mucilaginosum (non-swelling starch).
- polymer particles with starch esters and / or their salts, for example with sodium and / or aluminum salts of low-substituted half-esters of starch, in particular with sodium starch n-octenyl succinate of structural formula (I), in which R is the following Structure distinguished
- the mean particle diameter of the modified polysaccharides used for combination with the polymer particles according to the invention is advantageous to choose the mean particle diameter of the modified polysaccharides used for combination with the polymer particles according to the invention to be less than 20 ⁇ m, particularly advantageously less than 15 ⁇ m.
- modified polysaccharides which can be combined with the polymer particles according to the invention, is of course not intended to be limiting.
- Modified polysaccharides which are advantageous combination partners for the purposes of the present invention, are obtainable in numerous ways known per se, both chemical and physical. In principle, new ways of producing such polysaccharides are also conceivable. It is essential that the modified polysaccharides show amphiphilic properties and that they do not have a thickening effect.
- the total concentration of all pigments is greater than 0.1% by weight, particularly advantageously between 0.1% by weight and 30% by weight.
- concentration of amphiphilic microfine polymer particles according to the invention - likewise based on the total weight of the preparations - in the sense of the present invention preferably from the range 0.1% by weight to 30% by weight, advantageously 0, 5% to 10% by weight is to be selected
- the Pickering emulsions according to the invention can serve as the basis for cosmetic or dermatological formulations. These can be composed as usual and for example for the treatment and care of the skin, as a lip care product, as a demo product and as a make-up or make-up removal product in decorative cosmetics or as a light protection preparation
- the cosmetic and dermatological preparations according to the invention are applied to the skin in a sufficient amount in the manner customary for cosmetics
- cosmetic or topical dermatological compositions in the sense of the present invention, depending on their structure, can be used, for example, as skin protection cream, cleansing milk, sunscreen lotion, nutritional cream, day or night cream, etc. It is possible and advantageous, if appropriate, to use the compositions according to the invention as the basis for pharmaceutical formulations - to use gene
- the cosmetic and dermatological preparations according to the invention can contain cosmetic auxiliaries, as are usually used in such preparations, for example preservatives, bactericides, perfumes, substances for preventing foaming, dyes, pigments which have a coloring effect, thickeners, softening, moisturizing and / or moisturizing substances, fats, oils, waxes or other usual components of a cosmetic or dermatological formulation such as alcohols, polyols, polymers, foam stabilizers, electrolytes, organic solvents or silicone derivatives
- the preparations according to the invention are very good vehicles for cosmetic or dermatological active ingredients in the skin, advantageous active ingredients being antioxidants which can protect the skin against oxidative stress
- the preparations advantageously contain one or more antioxidants. All the antioxidants suitable or useful for cosmetic and / or dermatological applications can be used as cheap but nevertheless optional antioxidants. It is advantageous to use antioxidants as the only class of active ingredient, for example then , if a cosmetic or dermatological application is in the foreground, such as combating the oxidative stress on the skin. However, it is also advantageous to provide the stick preparations according to the invention with one or more antioxidants if the preparations are different To serve the purpose, for example as deodorants or sunscreens
- the antioxidants are particularly advantageously selected from the group consisting of amino acids (eg glycine, histidine, tyrosine, tryptophan) and their derivatives, imidazoles (eg urocanic acid) and their derivatives, peptides such as D, L-carnosine, D-carnosine, L -Carnosine and its derivatives (eg Anse ⁇ n), carotenoids, carotenes (eg ⁇ -carotene, ⁇ -carotene, lycopene) and their derivatives, chlorogenic acid and their derivatives, lipoic acid and its derivatives (eg dihydroliponic acid), aurothioglucose, Propylthiouracil and other thiols (e.g.
- amino acids eg glycine, histidine, tyrosine, tryptophan
- imidazoles eg urocanic acid
- peptides such as D, L-carnosine, D-
- thioredoxin glutathione, cysteine, cystine, cystamine and their glycosyl, N, acetyl, methyl, ethyl, propyl, amyl, butyl and lauryl, palmitoyl, oleyl, ⁇ , unoleyl, cholesteryl and glyceryl esters) and their salts, dilauryl thiodipropionate, distearyl thio dipropionate, thiodipropionic acid and their derivatives (esters, ethers, peptides, lipids, nucleotides, nucleosides and salts) as well as sulfoximine compounds (eg buthiomn-sulfoxmsulfone, homocysteine sulfone sulfone, homocysteine sulfone sulfate, homocysteine sulfone sulfate, homocysteine sulf
- ⁇ -hydroxy fatty acids e.g. ⁇ -hydroxy fatty acids, palmitic acid, phytic acid, lactofer ⁇ n
- ⁇ -hydroxy acids e.g. Citric acid, lactic acid, malic acid
- humic acid e.g. Citric acid, lactic acid, malic acid
- bile acid bile extracts
- bilirubin biliverdin
- EDTA EDTA
- EGTA unsaturated fatty acids and their derivatives
- vitamin E acetate
- vitamin A and derivatives vitamin A palmitate
- coniferyl benzoate of the benzoic resin rutmate and their Derivatives -Glycosylrutin, Ferulasaure Furfurylidenglucitol, Carnosin Butylhydroxytoluol, Butylhydroxyanisol, Nordihydroguajakh resin acid, Nordihydroguajaretklare, trihydroxybutyrophenon, uric acid and its derivatives, mannose and its derivatives, zinc and its derivatives (e.g. ZnO, ZnSO 4 ), selenium and its derivatives (e.g. selenomethionine), stilbenes and their derivatives (e.g. stilbene oxide and trans-stilbene oxide) the derivatives suitable according to the invention (salts, esters, ethers, sugars, nucleotides, nucleosides, peptides and lipids) of these active substances.
- the amount of the aforementioned antioxidants (one or more compounds) in the preparations according to the invention is preferably 0.001 to 30% by weight, particularly preferably 0.05-20% by weight, in particular 1-10% by weight, based on the total weight of the preparation.
- vitamin E and / or its derivatives represent the antioxidant (s)
- vitamin A or vitamin A derivatives or carotenes or their derivatives represent the antioxidant or antioxidants, it is advantageous to use their respective concentrations in the range from 0.001-10% by weight, based on the total weight of the formulation, to choose.
- the active ingredients can also be selected very advantageously from the group of lipophilic active ingredients, in particular from the following group:
- Cosmetic and dermatological preparations in the form of a sunscreen are also favorable. These preferably contain at least one UV-A filter substance and / or at least one UV-B filter substance and / or at least one further inorganic pigment from the group of the oxides of iron, zirconium, silicon, manganese, aluminum, cerium and mixtures thereof, and modifications where the oxides are the active agents.
- UV-A or UV-B filter substances are usually incorporated into day creams.
- Preparations according to the invention can advantageously contain substances which absorb UV radiation in the UV-B range, the total amount of filter substances, for. B. 0.1 wt .-% to 30 wt .-%, preferably 0.5 to 15 wt .-%, based on the total weight of the preparations to provide cosmetic preparations that the hair or the skin before protect the entire range of ultraviolet radiation.
- the emulsions according to the invention contain UV-B filter substances, they can be oil-soluble or water-soluble.
- Oil-soluble UV-B filters which are advantageous according to the invention are, for example:
- 3-benzylidene camphor derivatives preferably 3- (4-methylbenzylidene) camphor, 3-benzylidene camphor;
- 4-aminobenzoic acid preferably 4- (dimethylamino) benzoic acid (2-ethylhexyl) ester, 4- (dimethylamino) amyl benzoate,
- Esters of cinnamic acid preferably 4-methoxycinnamate (2-ethylhexyl) ester, 4-methoxycinnamate isopentyl ester, • esters of salicylic acid, preferably salicyl acid (2-ethylhexyl) ester, salicyl acid (4-isopropylbenzyl) ester, salicyl ester,
- benzophenone preferably 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxy-4'-methylbenzophenone, 2,2'-dihydroxy-4-methoxybenzophenone,
- esters of benzalmalonic acid preferably 4-methoxybenzalmalonic acid (2-ethylhexyl) ester
- T ⁇ azinden ⁇ vate symmetrically or asymmetrically substituted with respect to the C 3 axis of the basic tnazine body, preferably 4,4 ', 4 "- (1, 3,5-tr ⁇ az ⁇ n-2,4,6-t ⁇ ylt ⁇ m ⁇ no) - t ⁇ s-benzoic acid tr ⁇ s (2-ethylhexyl ester ) (symmetrical) and 2,4-B ⁇ s - ⁇ [4- (2-ethylhexyloxy) -2-hydroxy] phenyl ⁇ -6- (4-methoxyphenyl) -1, 3,5-t ⁇ az ⁇ n, 2,4 -B ⁇ s - ⁇ [4- (3-sulfonato) -2-hydroxy-propyioxy) -2-hydroxy] phenyl ⁇ -6- (4-methoxyphenyl) -1, 3,5-tr ⁇ az ⁇ n
- Benzot ⁇ azolde ⁇ vate preferably 2,2'-methylene-b ⁇ s- (6- (2H-benzot ⁇ azol-2-yl) -4- (1, 1, 3,3-tetramethylbutyl) phenol)
- Advantageous water-soluble UV-B filter substances are, for example
- Salts of 2-phenylbenz ⁇ m ⁇ dazol-5-sulfonic acid such as its sodium, potassium or T ⁇ -ethanolammonium salt, and the sulfonic acid itself
- Sulfonic acid derivatives of 3-benzylidene camphor such as 4- (2-oxo-3-bornylidene methyl) benzenesulfonic acid, 2-methyl-5- (2-oxo-3-bornylidene methyl) sulfonic acid and their salts.
- UV-B filters which can be used in the Pickering emulsions according to the invention, is of course not intended to be limiting.
- UV-A filters in Pickering emulsions according to the invention which have hitherto usually been contained in cosmetic preparations.
- These substances are preferably derivatives of dibenzoyl methane, in particular 1- (4'-tert-butylphenyl) -3- (4'-methoxyphenyl) propane-1, 3-dione and 1-phenyl-3- (4'-isopropylphenyl) propane-1,3-dione.
- UV-A filter substances are phenylene-1,4-bis (2-benzimidazyl) -3,3'-5,5'-tetrasulfonic acid:
- benzene-1,4-di (2-oxo-3-bornylidenemethyl-10-sulfonic acid) is also referred to as benzene-1,4-di (2-oxo-3-bornylidenemethyl-10-sulfonic acid) and is characterized by the following structure:
- UV filter substances are also so-called broadband filters, i.e. Filter substances that absorb both UV-A and UV-B radiation.
- An example of a broadband filter which can be used advantageously is ethylhexyl-2-cyano-3,3-diphenyl acrylate (octocrylene), which is available from BASF under the name Uvinul ® N 539 and is characterized by the following structure:
- UV-A filters Preparations which contain UV-A filters or so-called broadband filters are also the subject of the invention.
- the quantities used for the UV-B combination can be used.
- Preparations according to the invention can also advantageously be used as the basis for cosmetic deodorants or antiperspirants, so that in a particular embodiment the present invention relates to Pickering emulsions as the basis for cosmetic deodorants.
- Cosmetic deodorants are used to eliminate body odor that arises when the fresh, odorless sweat is decomposed by microorganisms.
- the usual cosmetic deodorants are based on different active principles.
- astringents primarily aluminum salts such as aluminum hydroxychloride (aluminum chlorohydrate) - can reduce the formation of sweat.
- the use of antimicrobial substances in cosmetic deodorants can reduce the bacterial flora on the skin. Ideally, only the odor-causing microorganisms should be effectively reduced. The sweat flow itself is not affected by this, in the ideal case only the microbial decomposition of the sweat is temporarily stopped.
- odor maskers such as the common perfume components, odor absorbers, for example the layered silicates described in patent application DE-P 40 09 347, of which in particular montmorillonite, kaolinite, llite, beidellite, nontronite, saponite , Hectorite, bentonite, smectite, furthermore, for example, zinc salts of ricinoleic acid.
- Germ-inhibiting agents are also suitable for being incorporated into the W / O emulsion sticks according to the invention.
- Advantageous substances are, for example, 2,4,4'-trichloro-2'-hydroxydiphenyl ether (irgasane), 1,6-di- (4-chlorophenylbiganido) hexane (chlorhexidine), 3,4,4'-trichlorocarbanilide, quaternary ammonium compounds, clove oil, mint oil, thyme oil, triethyl citrate, farnesol (3,7,11-trimethyl-2,6, 10-dodecatrien-1-ol) and those described in patent publications DE-37 40 186, DE-39 38 140, DE-42 04 321, DE-42 29 707, DE-43 09 372, DE-44 11 664, DE-195 41 967, DE-195 43 695, DE-195 43 696, DE-195 47 160, DE- 196 02 108, DE-196 02 110, DE-196 02 111, DE-196 31 003, DE-196 31 004 and DE-196 34 019 and the patents DE-
- the cosmetic deodorants according to the invention can be in the form of water-containing cosmetic preparations which can be applied from normal containers.
- the amount of the antiperspirant active ingredients or deodorants (one or more compounds) in the preparations is preferably 0.01 to 30% by weight, particularly preferably 0.1-20% by weight, in particular 1-10% by weight, based on the total weight of the preparation.
- the pens according to the invention are also excellent vehicles for dermatological active ingredients. They are particularly suitable as carriers for substances active against acne.
- Acne is a skin disease with various forms and causes, characterized by non-inflammatory and inflammatory nodules, starting from blocked hair follicles (comedones), which can lead to pustules, abscesses and scars.
- the most common is acne vulgaris, which mainly occurs during puberty.
- Causal conditions for acne vulgaris are cornification and constipation of the hair follicle mouth, the production of taig depending on the blood level of the male sex hormones and the production of free fatty acids and tissue-damaging enzymes by bacteria ⁇ Propionibacterium acnes).
- All common acne-active substances can be used to advantage, especially benzoyl peroxide, bituminosulfonates (ammonium, sodium and calcium salts of shale oil sulfonic acids), salicylic acid (2-hydroxybenzoic acid), miconazole (1- [2- (2,4- Dichlorobenzyloxy) -2- (2,4-dichlorophenyl) ethyl] imidazole) and derivatives, adapalene (6- [3- (1-adamantyl) -4-methoxyphenyl] -2-naphthoic acid), azelaic acid (nonandioic acid) , Mesulfen (2,7-dimethylthianthrene, C 1 H ⁇ 2 S 2 ) and aluminum oxide, zinc oxide and / or finely divided sulfur.
- the amount of the anti-acne agent (one or more compounds) in the preparations is preferably 0.01 to 30% by weight, particularly preferably 0.1-20% by weight, in particular 1-10% by weight, based on the total weight of the preparation.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Dispersion Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Toxicology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The invention relates to cosmetic or dermatological preparations constituting finely dispersed systems of the oil-in-water or water-in-oil type and containing: 1) an oil phase; 2) an aqueous phase; 3) at least one type of microfine polymer particles which (a) are present in the preparation in the form of solids and (b) have both hydrophilic and lipophilic properties and an amphiphilic character and can be dispersed in both water and oil; and 4) no more than 0.5 % by weight of one or more emulsifiers; as well as possibly other cosmetic or pharmaceutical aids, additives and/or active ingredients.
Description
Beschreibung description
Emulgatorfreie feindisperse Systeme vom Typ Öl-in-Wasser und Wasser-in-ÖIOil-in-water and water-in-oil type emulsifier-free finely dispersed systems
Die vorliegende Erfindung betrifft emulgatorfreie feindisperse Systeme vom Typ Öl-inWasser und Wasser-in-ÖI, bevorzugt als kosmetische oder dermatologische Zubereitungen.The present invention relates to emulsifier-free finely dispersed systems of the oil-in-water and water-in-oil type, preferably as cosmetic or dermatological preparations.
Unter Emulsionen versteht man im allgemeinen heterogene Systeme, die aus zwei nicht oder nur begrenzt miteinander mischbaren Flüssigkeiten bestehen, die üblicherweise als Phasen bezeichnet werden. In einer Emulsion ist eine der beiden Flüssigkeiten in Form feinster Tröpfchen in der anderen Flüssigkeit dispergiert.Emulsions are generally understood to mean heterogeneous systems which consist of two liquids which are immiscible or only miscible with one another to a limited extent and are usually referred to as phases. In an emulsion, one of the two liquids is dispersed in the other liquid in the form of very fine droplets.
Sind die beiden Flüssigkeiten Wasser und Öl und liegen Oltröpfchen fein verteilt in Wasser vor, so handelt es sich um eine ÖI-in-Wasser-Emulsion (O/W-Emulsion, z. B. Milch). Der Grundcharakter einer OΛ/V-Emulsion ist durch das Wasser geprägt. Bei einer Wasser-in-ÖI-Emulsion (W/O-Emulsion, z. B. Butter) handelt es sich um das umgekehrte Prinzip, wobei der Grundcharakter hier durch das Öl bestimmt wird.If the two liquids are water and oil and oil droplets are finely distributed in water, it is an oil-in-water emulsion (O / W emulsion, e.g. milk). The basic character of an OΛ / V emulsion is characterized by the water. A water-in-oil emulsion (W / O emulsion, e.g. butter) is the opposite principle, whereby the basic character is determined by the oil.
Um die dauerhafte Dispergierung einer Flüssigkeit in einer anderen zu erreichen, ist bei Emulsionen im herkömmlichen Sinn der Zusatz einer grenzflächenaktiven Substanz (Emulgator) notwendig. Emulgatoren weisen einen amphiphilen Molekülaufbau auf, bestehend aus einem polaren (hydrophilen) und einem unpolaren (lipophilen) Molekül- teil, die räumlich voneinander getrennt sind. In einfachen Emulsionen liegen in der einen Phase feindisperse, von einer Emulgatorhülle umschlossene Tröpfchen der zweiten Phase (Wassertröpfchen in W/O- oder Lipidvesikel in O/W-Emulsionen) vor. Emulgatoren setzen die Grenzflächenspannung zwischen den Phasen herab, indem sie an der Grenzfläche zwischen beiden Flüssigkeiten angeordnet sind. Sie bilden an der Phasen-
grenze Öl/Wasser Grenzflächenfilme aus, wodurch dem irreversiblen Zusammenfließen der Tröpfchen entgegengewirkt wird. Zur Stabilisierung von Emulsionen werden häufig Emulgatorgemische verwendet.In order to achieve permanent dispersion of one liquid in another, the addition of a surface-active substance (emulsifier) is necessary for emulsions in the conventional sense. Emulsifiers have an amphiphilic molecular structure consisting of a polar (hydrophilic) and a non-polar (lipophilic) part of the molecule, which are spatially separated from each other. In simple emulsions there are finely dispersed droplets of the second phase (water droplets in W / O or lipid vesicles in O / W emulsions) enclosed in an emulsifier shell. Emulsifiers reduce the interfacial tension between the phases by being located at the interface between the two liquids. They form at the live exclude oil / water interface films, which counteracts the irreversible confluence of the droplets. Mixtures of emulsifiers are often used to stabilize emulsions.
Herkömmliche Emulgatoren können entsprechend ihrem hydrophilen Molekülteil in ionische (anionische, kationische und amphotere) und nichtionische untergliedert werden: . Das wohl bekannteste Beispiel eines anionischen Emulgators ist die Seife, als die man gewöhnlich die wasserlöslichen Natrium- oder Kaliumsalze der gesättigten und ungesättigten höheren Fettsäuren bezeichnet. . Wichtige Vertreter der kationischen Emulgatoren sind die quartären Ammonium-Verbindungen. . Der hydrophile Molekülteil nichtionischer Emulgatoren besteht häufig aus Glycerin, Polyglycerin, Sorbitanen, Kohlenhydraten bzw. Polyoxyethylenglykolen und ist meistens über Ester- und Etherbindungen mit dem lipophilen Molekülteil verknüpft. Die- ser besteht üblicherweise aus Fettalkoholen, Fettsäuren oder Isofettsäuren.Conventional emulsifiers can be divided into ionic (anionic, cationic and amphoteric) and nonionic according to their hydrophilic part of the molecule:. The best-known example of an anionic emulsifier is soap, which is commonly referred to as the water-soluble sodium or potassium salts of the saturated and unsaturated higher fatty acids. . The quaternary ammonium compounds are important representatives of the cationic emulsifiers. . The hydrophilic part of the molecule of nonionic emulsifiers often consists of glycerol, polyglycerol, sorbitan, carbohydrates or polyoxyethylene glycols and is usually linked to the lipophilic part of the molecule via ester and ether bonds. This usually consists of fatty alcohols, fatty acids or isofatty acids.
Durch Variation der Struktur und der Größe des polaren und des unpolaren Molekülteils lassen sich Lipophilie und Hydrophilie von Emulgatoren in weiten Grenzen verändern.By varying the structure and size of the polar and non-polar part of the molecule, lipophilicity and hydrophilicity of emulsifiers can be changed within wide limits.
Entscheidend für die Stabilität einer Emulsion ist die richtige Auswahl der Emulgatoren. Dabei sind die Charakteristiken aller im System enthaltenen Stoffe zu berücksichtigen. Betrachtet man z. B. Hautpflegeemulsionen, so führen polare Ölkomponenten und beispielsweise UV-Filter zu Instabilitäten. Neben den Emulgatoren werden daher noch andere Stabilisatoren verwendet, die beispielsweise die Viskosität der Emulsion erhöhen und/oder als Schutzkolloid wirken.The correct choice of emulsifiers is decisive for the stability of an emulsion. The characteristics of all substances contained in the system must be taken into account. Looking at z. B. skin care emulsions, polar oil components and, for example, UV filters lead to instabilities. In addition to the emulsifiers, other stabilizers are therefore used which, for example, increase the viscosity of the emulsion and / or act as a protective colloid.
Emulsionen stellen einen wichtigen Produkttyp im Bereich kosmetischer und/oder dermatologischer Zubereitungen dar.Emulsions are an important product type in the field of cosmetic and / or dermatological preparations.
Kosmetische Zubereitungen werden im wesentlichen zur Hautpflege benutzt. Hautpflege im kosmetischen Sinn ist in erster Linie, daß die natürliche Funktion der Haut als Barriere gegen Umwelteinflüsse (z.B. Schmutz, Chemikalien, Mikroorganismen) und gegen den Verlust von körpereigenen Stoffen (z.B. Wasser, natürliche Fette, Elektro- lyte) gestärkt oder wiederhergestellt wird. Wird diese Funktion gestört, kann es zu ver-
stärkter Resorption toxischer oder allergener Stoffe oder zum Befall von Mikroorganismen und als Folge zu toxischen oder allergischen Hautreaktionen kommen.Cosmetic preparations are mainly used for skin care. Skin care in the cosmetic sense is primarily that the natural function of the skin as a barrier against environmental influences (eg dirt, chemicals, microorganisms) and against the loss of the body's own substances (eg water, natural fats, electrolytes) is strengthened or restored. If this function is disturbed, it can lead to stronger absorption of toxic or allergenic substances or infestation of microorganisms and, as a result, toxic or allergic skin reactions.
Ziel der Hautpflege ist es ferner, den durch tägliches Waschen verursachten Fett- und Wasserverlust der Haut auszugleichen. Dies ist gerade dann wichtig, wenn das natürliche Regenerationsvermögen nicht ausreicht. Außerdem sollen Hautpflegeprodukte vor Umwelteinflüssen, insbesondere vor Sonne und Wind, schützen und die Hautalterung verzögern.The aim of skin care is also to compensate for the loss of fat and water in the skin caused by daily washing. This is especially important when the natural regeneration ability is insufficient. In addition, skin care products are intended to protect against environmental influences, especially sun and wind, and to delay skin aging.
Kosmetische Zubereitungen werden auch als Desodorantien verwendet. Solche Formulierungen dienen dazu, Körpergeruch zu beseitigen, der entsteht, wenn der an sich geruchlose frische Schweiß durch Mikroorganismen zersetzt wird.Cosmetic preparations are also used as deodorants. Such formulations serve to eliminate body odor that arises when the odorless fresh sweat is decomposed by microorganisms.
Medizinische topische Zusammensetzungen enthalten in der Regel ein oder mehrere Medikamente in wirksamer Konzentration. Der Einfachheit halber wird zur eindeutigen Unterscheidung zwischen kosmetischer und medizinischer Anwendung und entsprechenden Produkten auf die gesetzlichen Bestimmungen der Bundesrepublik Deutschland verwiesen (z.B. Kosmetikverordnung, Lebensmittel- und Arzneimittelgesetz).Medical topical compositions usually contain one or more drugs in effective concentration. For the sake of simplicity, reference is made to the legal provisions of the Federal Republic of Germany for a clear distinction between cosmetic and medical use and corresponding products (e.g. cosmetics ordinance, food and drug law).
An sich ist die Verwendung der üblichen Emulgatoren in kosmetischen oder dermatologischen Zubereitungen unbedenklich. Dennoch können Emulgatoren, wie letztlich jede chemische Substanz, im Einzelfalle allergische oder auf Überempfindlichkeit des Anwenders beruhende Reaktionen hervorrufen.As such, the use of the customary emulsifiers in cosmetic or dermatological preparations is harmless. Nevertheless, emulsifiers, like any chemical substance, can cause allergic or hypersensitive reactions in individual cases.
So ist beispielsweise bekannt, daß bestimmte Lichtdermatosen durch gewisse Emulgatoren, aber auch durch verschiedene Fette und gleichzeitige Exposition von Sonnenlicht ausgelöst werden. Solche Lichtdermatosen werden auch "Mallorca-Akne" genannt. Es hat daher nicht an Versuchen gefehlt, die Menge an üblichen Emulgatoren auf ein Minimum, im Idealfall sogar vollständig zu reduzieren.For example, it is known that certain light dermatoses are triggered by certain emulsifiers, but also by various fats and simultaneous exposure to sunlight. Such light dermatoses are also called "Mallorca acne". There has been no shortage of attempts to reduce the amount of conventional emulsifiers to a minimum, ideally even completely.
Eine Reduktion der benötigten Emulgatormenge kann z. B. erreicht werden, wenn ausgenutzt wird, daß feinstverteilte Feststoffteilchen eine zusätzlich stabilisierende Wirkung haben. Dabei kommt es zu einer Anreicherung des festen Stoffes an der Phasengrenze Öl/Wasser in Form einer Schicht, wodurch Zusammenfließen der dispersen Phasen ver-
hindert wird. Von wesentlicher Bedeutung sind dabei nicht die chemischen, sondern die Oberflächeneigenschaften der Feststoffpartikel.A reduction in the amount of emulsifier required can, for. B. can be achieved if it is used that finely divided solid particles have an additional stabilizing effect. The solid material accumulates at the oil / water phase boundary in the form of a layer, which causes the disperse phases to flow together. is prevented. It is not the chemical, but the surface properties of the solid particles that are essential.
Pickering stellte um 1910 Paraffin-Wasser-Emulsionen her, die nur durch den Zusatz verschiedener Feststoffe wie basisches Kupfersulfat, basisches Eisensulfat oder andere Metallsulfate stabilisiert wurden. Diese Art von Emulsionen wird daher auch als Pickering-Emulsion bezeichnet. Für diese Form von Emulsionen postulierte Pickering die folgenden Bedingungen:Around 1910, Pickering produced paraffin-water emulsions that were only stabilized by adding various solids such as basic copper sulfate, basic iron sulfate or other metal sulfates. This type of emulsions is therefore also called a Pickering emulsion. Pickering postulated the following conditions for this form of emulsions:
(1) Die Feststoffpartikel sind nur dann zur Stabilisierung geeignet, wenn sie deutlich kleiner sind als die Tröpfchen der inneren Phase und nicht zur Agglomeratbildung neigen.(1) The solid particles are only suitable for stabilization if they are significantly smaller than the droplets of the inner phase and do not tend to form agglomerates.
(2) Wichtige Eigenschaft eines emulsionsstabilisierenden Feststoffs ist außerdem seine Benetzbarkeit. D.h. zur Stabilisierung einer OΛΛ/-Emulsion muß der Feststoff beispielsweise leichter von Wasser als von Öl benetzbar sein.(2) Another important property of an emulsion-stabilizing solid is its wettability. That To stabilize an OΛΛ / emulsion, the solid must, for example, be wettable more easily by water than by oil.
Sozusagen die Urformen von Pickering-Emulsionen tauchten zunächst als unerwünschte Nebeneffekte bei unterschiedlichen technischen Prozessen auf, wie z. B. bei der sekundären Erdölförderung, der Extraktion von Bitumen aus Teersand und anderen Trennungsverfahren, an denen zwei nicht miteinander mischbare Flüssigkeiten und feine, dispergierte Feststoffpartikel beteiligt sind. Im allgemeinen handelt es sich hierbei um W/O-Emulsionen, die durch mineralische Feststoffe stabilisiert werden. Dementsprechend stand die Untersuchung entsprechender Systeme, wie z. B. der Systeme Öl- Wasser-Ruß oder Öl-Wasser-Schieferstaub zunächst im Mittelpunkt der Forschungsaktivitäten.So to speak, the original forms of Pickering emulsions first appeared as undesirable side effects in various technical processes, such as. B. in the secondary oil production, the extraction of bitumen from tar sand and other separation processes, in which two immiscible liquids and fine, dispersed solid particles are involved. In general, these are W / O emulsions that are stabilized by mineral solids. Accordingly, the investigation of corresponding systems, such. B. the systems oil-water-soot or oil-water-slate dust initially in the focus of the research activities.
Grundlegende Untersuchungen haben dabei gezeigt, daß ein Charakteristikum für eine Pickering-Emulsion ist, daß die Feststoffpartikel an der Grenzfläche zwischen den beiden flüssigen Phasen angeordnet sind und dort sozusagen eine mechanische Barriere gegen die Vereinigung der Flüssigkeitströpfen bilden.Basic investigations have shown that a characteristic of a Pickering emulsion is that the solid particles are arranged at the interface between the two liquid phases and form, so to speak, a mechanical barrier against the unification of the liquid droplets.
Eine relativ neue technische Entwicklung ist es, Pickering-Emulsionen als Grundlage für kosmetische oder dermatologische Zubereitungen zu verwenden.
Eine Möglichkeit, eine Feststoffstabilisierung in einer kosmetischen oder dermatologischen Zubereitung vorzunehmen, ist nach May-Alert {Pharmazie in unserer Zeit, 15. Jahrg. 1986, Nr. 1, 1-7) beispielsweise, Emulgatorgemische zu verwenden, die sowohl anionische als auch kationische Tenside enthalten. Da beim Zusammengeben von Anion- und Kationtensiden immer unlösliche, elektroneutrale Verbindungen ausfallen, läßt sich durch gezieltes Ausfällen dieser neutralen Tenside in der Grenzfläche Öl/Wasser eine zusätzliche Feststoffstabilisierung im Sinne einer Pickering-Emulsion erreichen.A relatively new technical development is to use Pickering emulsions as the basis for cosmetic or dermatological preparations. According to May-Alert (Pharmacy in our Time, 15th year 1986, No. 1, 1-7), one way of stabilizing the solids in a cosmetic or dermatological preparation is to use emulsifier mixtures which are both anionic and cationic Contain surfactants. Since insoluble, electroneutral compounds always fail when anion and cationic surfactants are combined, specific precipitation of these neutral surfactants in the oil / water interface can achieve additional solid stabilization in the sense of a Pickering emulsion.
Die Europäische Offenlegungsschrift 0 686 391 beschreibt Emulsionen vom Typ Wasser-in-ÖI, die frei von oberflächenaktiven Substanzen sind und nur durch Feststoffe stabilisiert werden. Zur Stabilisierung werden hier sphärische Polyalkylsilsesquioxan-Parti- kel eingesetzt, die einen Durchmesser von 100 nm bis zu 20 μm haben. Diese Emulsionen können nach dem oben gesagten als Pickering-Emulsionen bezeichnet werden.European laid-open specification 0 686 391 describes water-in-oil emulsions which are free of surface-active substances and are only stabilized by solids. Spherical polyalkylsilsesquioxane particles with a diameter of 100 nm to 20 μm are used for stabilization. These emulsions can be referred to as Pickering emulsions after the above.
Der Stand der Technik kennt neben den beschriebenen Pickering-Emulsionen weitere emulgatorfreie, feindisperse kosmetische oder dermatologische Zubereitungen, die im allgemeinen als Hydrodispersionen bezeichnet werden. Hydrodispersionen stellen Dispersionen einer flüssigen, halbfesten oder festen inneren (diskontinuierlichen) Lipid- phase in einer äußeren wäßrigen (kontinuierlichen) Phase dar.In addition to the Pickering emulsions described, the prior art knows other emulsifier-free, finely dispersed cosmetic or dermatological preparations which are generally referred to as hydrodispersions. Hydrodispersions are dispersions of a liquid, semisolid or solid inner (discontinuous) lipid phase in an outer aqueous (continuous) phase.
Bei Hydrodispersionen einer flüssigen Lipidphase in einer äußeren wäßrigen Phase kann die Stabilität beispielsweise dadurch gewährleistet werden, daß in der wäßrigen Phase ein Gelgerüst aufgebaut wird, in welchem die Lipidtröpfchen stabil suspendiert sind. Die Deutsche Offenlegungsschrift 44 25 268 beschreibt stabile feindisperse, emulgatorfreie kosmetische oder dermatologische Zubereitungen vom Typ Öl-in-Wasser, die neben einer Öl- und einer Wasserphase einen oder mehrere Verdicker aus der Gruppe der Acrylsäurepolymere, Polysaccharide und deren Alkylether enthalten, wobei für diese Verdicker eine Grenzflächenspannungserniedrigung nicht meßbar sein darf.In the case of hydrodispersions of a liquid lipid phase in an outer aqueous phase, the stability can be ensured, for example, by building a gel structure in the aqueous phase in which the lipid droplets are stably suspended. German Offenlegungsschrift 44 25 268 describes stable, finely dispersed, emulsifier-free cosmetic or dermatological preparations of the oil-in-water type which, in addition to an oil and a water phase, contain one or more thickeners from the group of acrylic acid polymers, polysaccharides and their alkyl ethers, and for these Thickener an interfacial tension reduction must not be measurable.
Basierend auf ähnlichen Hydrodispersionen werden in der Deutschen Offenlegungsschrift 43 03 983 kosmetische oder dermatologische Lichtschutzformulierungen offenbart, die im wesentlichen frei von Emulgatoren sind, wobei in die Lipidphase der Hydro-
dispersion anorganische Mikropigmente eingearbeitet sind, die als UV-Filtersubstanzen dienen.Based on similar hydrodispersions, German Offenlegungsschrift 43 03 983 discloses cosmetic or dermatological light protection formulations which are essentially free from emulsifiers, the hydrochloride being inorganic micropigments are incorporated, which serve as UV filter substances.
Aufgabe der vorliegenden Erfindung war, den Stand der Technik um kosmetische oder dermatologische Zubereitungen zu bereichern, in welchen auf jeglichen Einsatz von Emulgatoren herkömmlicher Art verzichtet werden kann.The object of the present invention was to enrich the prior art with cosmetic or dermatological preparations, in which any use of conventional emulsifiers can be dispensed with.
Erstaunlicherweise wird diese Aufgabe gelöst durchAmazingly, this problem is solved by
kosmetische oder dermatologische Zubereitungen, die feindisperse Systeme vom Typ Öl-in-Wasser oder Wasser-in-ÖI darstellen, enthaltendcontaining cosmetic or dermatological preparations which are finely dispersed systems of the oil-in-water or water-in-oil type
1. eine Olphase,1. an oil phase,
2. eine Wasserphase,2. a water phase,
3. mindestens eine Sorte von mikrofeinen Polymerpartikeln, welche (a) in der Zubereitung in Form von Feststoffen vorliegen und welche3. at least one type of microfine polymer particles which (a) are present in the preparation in the form of solids and which
(b) sowohl hydrophile als auch lipophile Eigenschaften zeigen, welche also amphiphilen Charakter besitzen und sowohl in Wasser als auch in Öl disper- gierbar sind und(b) show both hydrophilic and lipophilic properties, which therefore have amphiphilic character and are dispersible in both water and oil, and
4. höchstens 0,5 Gew. % eines oder mehrerer Emulgatoren sowie gegebenenfalls weitere kosmetische oder pharmazeutische Hilfs-, Zusatz- und/oder Wirkstoffe enthaltend.4. containing at most 0.5% by weight of one or more emulsifiers and, if appropriate, further cosmetic or pharmaceutical auxiliaries, additives and / or active ingredients.
Es ist erfindungsgemäß besonders vorteilhaft, wenn die Zubereitungen deutlich weni- ger als 0,5 Gew.-% eines oder mehrerer Emulgatoren enthalten bzw. sogar gänzlich emulgatorfrei sind.It is particularly advantageous according to the invention if the preparations contain significantly less than 0.5% by weight of one or more emulsifiers or are even completely emulsifier-free.
Die erfindungsgemäßen Zubereitungen stellen Abmischungen aus Ölen bzw. öllöslichen Substanzen und Wasser bzw. wasserlöslichen Komponenten dar, die durch den Zusatz der mikrofeinen Polymerpartikel stabilisiert werden und keinen Emulgator im herkömmlichen Sinn enthalten müssen. Die Stabilisierung wird dadurch erreicht, daß sich die mikrofeineπ Polymerpartikel an die Tröpfchen der dispersen Phase anlagern und sozusagen eine mechanische Barriere bilden, die das Koaleszieren, d. h. das Zusammenfließen der Tröpfchen verhindert.
Die erfindungsgemäßen Zubereitungen sind in jeglicher Hinsicht überaus befriedigende Präparate, die erstaunlicherweise höchst variabel in ihrem Wasser-Fettphasen-Verhältnis sind und zudem gegenüber dem Stand der Technik den Vorteil bieten, daß hohe Mengen an Ölen in Wasser stabil eingearbeitet werden können. Es war zudem überraschend, daß bei Befolgung der hiermit offenbarten Lehre zum technischen Handeln sowohl Pickering-Emulsionen vom Typ Wasser-in-ÖI als auch Pickering-Emulsionen vom Typ Öl-in-Wasser hergestellt werden können.The preparations according to the invention are mixtures of oils or oil-soluble substances and water or water-soluble components which are stabilized by the addition of the microfine polymer particles and do not have to contain an emulsifier in the conventional sense. The stabilization is achieved in that the microfine polymer particles attach to the droplets of the disperse phase and form, so to speak, a mechanical barrier that prevents the coalescing, ie the confluence of the droplets. The preparations according to the invention are extremely satisfactory preparations in every respect, which are surprisingly highly variable in their water-fat phase ratio and also offer the advantage over the prior art that large amounts of oils can be incorporated stably in water. It was also surprising that if the teaching on technical action disclosed herewith is followed, both Pickering emulsions of the water-in-oil type and Pickering emulsions of the oil-in-water type can be produced.
Vorteilhafte mikrofeine Polymerpartikel sind im Sinne der vorliegenden Erfindung beispielsweise Polycarbonate, Polyether, Polyethylen, Polypropylen, Polyvinylchlorid, Polystyrol, Polyamide, Polyacrylate und dergleichen mehr.Advantageous microfine polymer particles for the purposes of the present invention are, for example, polycarbonates, polyethers, polyethylene, polypropylene, polyvinyl chloride, polystyrene, polyamides, polyacrylates and the like.
Erfindungsgemäß vorteilhaft sind beispielsweise mikrofeine Polyamid-Partikel, welche unter der Handelsbezeichnung SP-500 bei der Firma TORAY erhältlich sind. Ferner vorteilhaft sind Polyamid 6- (auch: Nylon 6) bzw. Polyamid 12- (auch: Nylon 12) Partikel. Polyamid 6 ist das aus ε-Aminocapronsäure (6-Aminohexansäure) oder ε-Caprolactam aufgebaute Polyamid [Poly(ε-caprolactam)], und Polyamid 12 ist ein Poly(ε-Iaurinlactam) aus ε-Laurinlactam. Vorteilhaft im Sinne der vorliegenden Erfindung sind beispielsweise Orgasol® 1002 (Polyamid 6) und Orgasol® 2002 (Polyamid 12) von der Firma ELF ATOCHEM.According to the invention, for example, microfine polyamide particles which are available under the trade name SP-500 from TORAY are advantageous. Polyamide 6 (also: nylon 6) or polyamide 12 (also: nylon 12) particles are also advantageous. Polyamide 6 is the polyamide [poly (ε-caprolactam)] composed of ε-aminocaproic acid (6-aminohexanoic acid) or ε-caprolactam, and polyamide 12 is a poly (ε-lauric lactam) made of ε-laurolactam. Advantageous for the purposes of the present invention are, for example Orgasol ® 1002 (polyamide 6) and Orgasol ® 2002 (polyamide 12) from ELF ATOCHEM.
Weitere vorteilhafte Polymerpartikel sind mikrofeine Polymethacrylate. Solche Partikel sind beispielsweise unter der Handelsbezeichnung POLYTRAP® bei der Firma DOW CHEMICAL erhältlich.Microfine polymethacrylates are further advantageous polymer particles. Such particles are available, for example, under the trade name POLYTRAP ® from DOW CHEMICAL.
Es ist insbesondere vorteilhaft, wenngleich nicht zwingend, wenn die verwendeten mikrofeinen Polymerpartikel oberflächlich beschichtet sind. Diese Oberflächenbehandlung kann darin bestehen, daß die Pigmente nach an sich bekannten Verfahren mit einer dünnen hydrophilen Schicht versehen werden. Vorteilhafte Beschichtungen bestehen beispielsweise aus TiO2, ZrO2 oder auch weiteren Polymeren, wie beispielsweise Polymethylmethacrylat.
Besonders vorteilhafte mikrofeine Polymerpartikel im Sinne der vorliegenden Erfindung sind ferner nach dem in der US-Patentschrift 4,898,913 beschriebenen Verfahren zur hydrophilen Beschichtung hydrophober Polymerpartikel erhältlich.It is particularly advantageous, although not essential, if the microfine polymer particles used are coated on the surface. This surface treatment can consist in that the pigments are provided with a thin hydrophilic layer by methods known per se. Advantageous coatings consist, for example, of TiO 2 , ZrO 2 or other polymers, such as polymethyl methacrylate. Particularly advantageous microfine polymer particles for the purposes of the present invention are also obtainable by the process for the hydrophilic coating of hydrophobic polymer particles described in US Pat. No. 4,898,913.
Vorteilhaft in allen vorgenannten Fällen ist es, den mittleren Partikeldurchmesser der verwendeten mikrofeinen Polymerpartikel kleiner als 100 μm, besonders vorteilhaft kleiner als 50 μm zu wählen. Dabei ist es im wesentlichen unerheblich, in welcher Form (Plättchen, Stäbchen, Kügelchen etc.) die verwendeten Polymerpartikel vorliegen.In all of the aforementioned cases, it is advantageous to choose the average particle diameter of the microfine polymer particles used to be less than 100 μm, particularly advantageously less than 50 μm. It is essentially irrelevant in which form (platelets, rods, beads, etc.) the polymer particles used are present.
Es ist ferner vorteilhaft, wenngleich nicht zwingend, die erfindungsgemäßen amphiphi- len, mikrofeinen Polymerpartikel mit weiteren amphiphilen Pigmenten zu kombinieren, welche gegebenenfalls auch zur Stabilisierung der Pickering-Emulsionen beitragen können.It is also advantageous, although not essential, to combine the amphiphilic, microfine polymer particles according to the invention with further amphiphilic pigments, which may also contribute to stabilizing the Pickering emulsions.
Solche Pigmente sind beispielsweise mikronisierte, anorganische Pigmente, die gewählt werden aus der Gruppe der amphiphilen Metalloxide, insbesondere aus der Gruppe Titandioxid, Zinkoxid, Siliciumdioxid bzw. Silicate (z. B. Talkum), wobei die Metalloxide sowohl einzeln als auch im Gemisch vorliegen können. Dabei ist es im wesentlichen unerheblich, in welcher der gegebenenfalls natürlich vorkommenden Modifikationen die verwendeten amphiphilen Metalloxide vorliegen.Such pigments are, for example, micronized, inorganic pigments which are selected from the group of amphiphilic metal oxides, in particular from the group titanium dioxide, zinc oxide, silicon dioxide or silicates (for example talcum), where the metal oxides can be present either individually or in a mixture . It is essentially irrelevant in which of the possibly naturally occurring modifications the amphiphilic metal oxides used are present.
Der mittlere Partikeldurchmesser der zur Kombination mit erfindungsgemäßen Polymerpartikel verwendeten amphiphilen Metalloxide wird vorzugsweise zwischen 1 nm und 200 nm, besonders vorteilhaft zwischen 5 nm und 100 nm gewählt.The average particle diameter of the amphiphilic metal oxides used for combination with polymer particles according to the invention is preferably selected between 1 nm and 200 nm, particularly advantageously between 5 nm and 100 nm.
Vorteilhaft im Sinne der vorliegenden Erfindung ist es, die erfindungsgemäßen amphiphilen mikrofeinen Polymerpartikel mit unbehandelten, nahezu reinen, amphiphilen Metalloxidpartikeln zu kombinieren, insbesondere mit solchen, welche auch als Farbstoff in der Lebensmittelindustrie und/oder als Absorber von UV-Strahlung in Sonnenschutz- mittein verwendet werden können. Vorteilhaft sind beispielsweise die bei der Firma Merck erhältlichen Zinkoxid-Pigmente sowie solche, die unter den Handelsbezeichnungen Zinkoxid neutral bei Haarmann & Reimer oder NanoX von der Harcros Chemical Group erhältlich sind.
Ein weiteres vorteilhaftes, unbehandeltes Pigment ist Bornitrid. Erfindungsgemäß werden das oder die mikrofeinen Polymerpartikel bevorzugt mit den im folgenden aufgelisteten Bornitriden kombiniert:For the purposes of the present invention, it is advantageous to combine the amphiphilic microfine polymer particles according to the invention with untreated, almost pure, amphiphilic metal oxide particles, in particular with those which are also used as a dye in the food industry and / or as an absorber of UV radiation in sunscreen agents can be. Advantageous are, for example, the zinc oxide pigments available from Merck and those that are available under the trade names zinc oxide neutral from Haarmann & Reimer or NanoX from the Harcros Chemical Group. Another advantageous, untreated pigment is boron nitride. According to the invention, the microfine polymer particle or particles are preferably combined with the boron nitrides listed below:
Handelsname erhältlich beiTrade name available from
Boron Nitride Powder Advanced Ceramics Boron Nitride Powder Sintec Keramik Ceram Blanche KawasakiBoron Nitride Powder Advanced Ceramics Boron Nitride Powder Sintec Ceramics Ceram Blanche Kawasaki
HCST Boron Nitride StarkHCST Boron Nitride Stark
Tres BN® CarborundumTres BN ® Carborundum
Wacker-Bornitrid BNP Wacker-ChemieWacker boron nitride BNP Wacker-Chemie
Der mittlere Partikeldurchmesser der verwendeten Bornitridpartikel wird vorzugsweise kleiner als 20 μm, insbesondere kleiner als 15 μm gewählt.The average particle diameter of the boron nitride particles used is preferably chosen to be less than 20 μm, in particular less than 15 μm.
Erfindungsgemäß vorteilhaft ist ferner die Kombination von mikrofeinen Polymerparti- kein mit amphiphilen anorganischen Pigmenten, die oberflächlich wasserabweisend behandelt („gecoatet") sind, wobei gleichzeitig ein amphiphiler Charakter dieser Pigmente gebildet werden bzw. erhalten bleiben soll. Diese Oberflächenbehandlung kann darin bestehen, daß die Pigmente nach an sich bekannten Verfahren mit einer dünnen hydrophoben Schicht versehen werden.Also advantageous according to the invention is the combination of microfine polymer particles with amphiphilic inorganic pigments which have been surface-treated ("coated") in a water-repellent manner, and at the same time an amphiphilic character of these pigments is to be formed or maintained. This surface treatment can consist in that the Pigments are provided with a thin hydrophobic layer by methods known per se.
Ein solches Verfahren, das im folgenden am Beispiel von Titandioxid beschrieben wird, besteht beispielsweise darin, daß die hydrophobe Oberflächenschicht nach einer Reaktion gemäßOne such method, which is described below using the example of titanium dioxide, consists, for example, in that the hydrophobic surface layer after a reaction according to
n TiO2 + m (RO)3 Si-R' → n TiO2 (oberfl.)n TiO 2 + m (RO) 3 Si-R '→ n TiO 2 (surface)
erzeugt wird, n und m sind dabei nach Belieben einzusetzende stöchiometrische Parameter, R und R' die gewünschten organischen Reste. Besonders vorteilhafte Kombinationspartner sind TiO2-Pigmente, beispielsweise die mit Aluminiumstearat beschichteten, unter der Handelsbezeichnung MT 100 T bei der Firma TAYCA erhältlichen.
Eine weitere vorteilhafte Beschichtung der Kombinationspartner besteht aus Dimethyl- polysiloxan (auch: Dimethicone), einem Gemisch vollmethylierter, linearer Siloxanpoly- mere, die endständig mit Trimethylsiloxy-Einheiten blockiert sind. Besonders vorteilhaft im Sinne der vorliegenden Erfindung ist die Kombination von mikrofeinen Polymerparti- kein mit Zinkoxid-Pigmenten, die auf diese Weise beschichtet werden. Vorteilhafte Kombinationspartner sind auch bei der Firma Carborundum unter der Handelsbezeichnung Tres BN® UHP 1106 erhältliche, mit Dimethicone behandelte Bornitridpartikel.is generated, n and m are stoichiometric parameters to be used at will, R and R 'are the desired organic radicals. Particularly advantageous combination partners are TiO 2 pigments, for example those coated with aluminum stearate, available under the trade name MT 100 T from TAYCA. Another advantageous coating of the combination partners consists of dimethylpolysiloxane (also: Dimethicone), a mixture of fully methylated, linear siloxane polymers which are blocked at the end with trimethylsiloxy units. The combination of microfine polymer particles with zinc oxide pigments, which are coated in this way, is particularly advantageous in the sense of the present invention. Advantageous combination partners are also available from Carborundum under the trade name Tres BN ® UHP 1106, boron nitride particles treated with dimethicone.
Vorteilhafte, beschichtete Bornitridpartikel sind ferner solche, die mit Polymethylhydro- gensiloxan behandelt sind, einem linearen Polysiloxan, welches auch als Methicone bezeichnet wird. Vorteilhafte, mit Methicone behandelte Bornitridpartikel sind beispielsweise die bei der Firma Carborundum unter der Handelsbezeichnung Tres BN® UHP 1107 erhältlichen.Advantageous, coated boron nitride particles are also those which have been treated with polymethylhydrogensiloxane, a linear polysiloxane, which is also referred to as methicone. Advantageous boron nitride particles treated with methicone are, for example, those available from Carborundum under the trade name Tres BN® UHP 1107.
Günstig im Sinne der vorliegenden Erfindung ist ferner, wenn die neben mikrofeinen Polymerpartikeln verwendeten anorganischen amphiphilen Pigmente mit einem Gemisch aus Dimethylpolysiloxan, insbesondere Dimethylpolysiloxan mit einer durchschnittlichen Kettenlänge von 200 bis 350 Dimethylsiloxan-Einheiten, und Silicagel beschichtet sind, welches auch als Simethicone bezeichnet wird. Es ist insbesondere von Vorteil, wenn die anorganischen Pigmente zusätzlich mit Aluminiumhydroxid bzw. Aluminiumoxidhydrat (auch: Alumina, CAS-Nr.: 1333-84-2) beschichtet sind. Besonders vorteilhafte Kombinationspartner sind Titandioxide, die mit Simethicone und Alumina beschichtet sind, wobei die Beschichtung auch Wasser enthalten kann. Ein Beispiel hierfür ist das unter dem Handelsnamen Eusolex T2000 bei der Firma Merck erhältliche Titandioxid.It is also advantageous in the sense of the present invention if the inorganic amphiphilic pigments used in addition to microfine polymer particles are coated with a mixture of dimethylpolysiloxane, in particular dimethylpolysiloxane with an average chain length of 200 to 350 dimethylsiloxane units, and silica gel, which is also referred to as simethicone. It is particularly advantageous if the inorganic pigments are additionally coated with aluminum hydroxide or aluminum oxide hydrate (also: alumina, CAS no .: 1333-84-2). Particularly advantageous combination partners are titanium dioxides which are coated with simethicone and alumina, the coating also being able to contain water. An example of this is the titanium dioxide available from Merck under the trade name Eusolex T2000.
Vorteilhaft im Sinne der vorliegenden Erfindung ist ferner die Kombination von mikrofeinen Polymerpartikeln mit einer Mischung verschiedener anorganischer, amphiphiler Pigmenttypen sowohl innerhalb eines Kristalls, beispielsweise als Eisenmischoxid oder Talkum (Magnesiumsilicat), als auch durch Mischung mehrerer Metalloxidtypen inner- halb einer Zubereitung. Besonders vorteilhafte Kombinationspartner sind Magnesium- silicate, beispielsweise die unter der Handelsbezeichnung Talkum Micron bei der Firma Grolmann erhältlichen.
Die erfindungsgemäßen amphiphilen mikrofeinen Polymerpartikel können ferner vorteilhaft mit weiteren Pigmenten kombiniert werden, beispielsweise mit Titandioxidpigmenten, die mit Octylsilanol beschichtet sind, und/oder mit Siliciumdioxidpartikeln, die oberflächlich wasserabweisend behandelt sind. Zur Kombination geeignete Siliciumdioxid- partikel sind beispielsweise sphärische Polyalkylsilsesquioxan-Partikel wie sie in der Europäischen Offenlegungsschrift 0 686 391 erwähnt werden. Solche Poiyalkylsilses- quioxan-Partikel sind beispielsweise unter den Handelsbezeichnungen Aerosil R972 und Aerosil 200V bei der Firma Degussa erhältlich.Another advantage of the present invention is the combination of microfine polymer particles with a mixture of different inorganic, amphiphilic pigment types both within a crystal, for example as iron mixed oxide or talc (magnesium silicate), as well as by mixing several metal oxide types within one preparation. Particularly advantageous combination partners are magnesium silicates, for example those available from Grolmann under the trade name Talkum Micron. The amphiphilic microfine polymer particles according to the invention can furthermore advantageously be combined with other pigments, for example with titanium dioxide pigments which are coated with octylsilanol, and / or with silicon dioxide particles which have been treated to be water-repellent on the surface. Silicon dioxide particles suitable for combination are, for example, spherical polyalkylsilsesquioxane particles as mentioned in European laid-open specification 0 686 391. Such polyalkylsilsesquioxane particles are available, for example, from Degussa under the trade names Aerosil R972 and Aerosil 200V.
Die erfindungsgemäßen amphiphilen mikrofeinen Polymerpartikel werden ferner vorzugsweise mit amphiphilen modifizierten Polysacchariden kombiniert, welche keine verdickenden Eigenschaften zeigen.The amphiphilic microfine polymer particles according to the invention are furthermore preferably combined with amphiphilic modified polysaccharides which do not show any thickening properties.
Solche amphiphilen Polysaccharide sind beispielsweise durch Umsetzung von Stärke mit mono-, bi- oder polyfunktionellen Reagenzien bzw. Oxidations-Mitteln in weitgehend polymeranalog verlaufenden Reaktionen erhältlich.Such amphiphilic polysaccharides can be obtained, for example, by reacting starch with mono-, bi- or polyfunctional reagents or oxidizing agents in reactions which are largely polymer-analogous.
Diese Reaktionen basieren im wesentlichen auf Umwandlungen der Hydroxy-Gruppen der Polyglucane durch Veretherung, Veresterung oder selektive Oxidation. Dabei entstehen z. B. sogenannte Stärkeether und Stärkeester der allgemeinen StrukturformelThese reactions are essentially based on conversions of the hydroxyl groups of the polyglucans by etherification, esterification or selective oxidation. This creates z. B. so-called starch ethers and starch esters of the general structural formula
Strukturformel (I) worin R beispielsweise ein Wasserstoff und/oder einen Alkyl- und/oder Aralkylrest (im Fall der Stärkeether) oder ein Wasserstoff und/oder einen organischen und/oder anorganischen Säure-Rest (im Fall der Stärkeester) darstellen kann. Stärkeether und Stärkeester sind vorteilhafte Kombinationspartner im Sinne der vorliegenden Erfindung.
Besonders vorteilhaft ist es, die erfindungsgemäßen Polymerpartikel mit Stärkeethern zu kombinieren, z. B. mit solchen, die durch Veretherung von Stärke mit Tetramethylolace- tylendiharnstoff erhältlich sind und welche als Amylum non mucilaginosum (nicht quellende Stärke) bezeichnet werden. .Structural formula (I) in which R can represent, for example, a hydrogen and / or an alkyl and / or aralkyl radical (in the case of starch ethers) or a hydrogen and / or an organic and / or inorganic acid radical (in the case of starch esters). Starch ethers and starch esters are advantageous combination partners in the sense of the present invention. It is particularly advantageous to combine the polymer particles of the invention with starch ethers, e.g. B. with those which are obtainable by etherification of starch with tetramethylolacetylene diurea and which are referred to as Amylum non mucilaginosum (non-swelling starch). ,
Insbesondere vorteilhaft ist ferner die Kombination von Polymerpartikeln mit Stärkeestern und/oder deren Salzen, beispielsweise mit Natrium- und/oder Aluminiumsalzen niedrigsubstituierter Halbester der Stärke, insbesondere mit Natrium Stärke n-Octenyl- succinat der Strukturformel (I), worin R sich durch die folgende Struktur auszeichnetAlso particularly advantageous is the combination of polymer particles with starch esters and / or their salts, for example with sodium and / or aluminum salts of low-substituted half-esters of starch, in particular with sodium starch n-octenyl succinate of structural formula (I), in which R is the following Structure distinguished
und welches z. B. unter der Handelsbezeichnung Amiogum® 23 bei der Firma CERESTAR erhältlich ist sowie mit Aluminium Stärke Octenylsuccinat, insbesondere mit den unter den Handelsbezeichnungen Dry Flo® Elite LL und Dry Flo® PC bei der Firma CERESTAR erhältlichen. and which z. B. is available under the trade name Amiogum ® 23 from CERESTAR and with aluminum starch octenyl succinate, in particular with those available under the trade names Dry Flo ® Elite LL and Dry Flo ® PC from CERESTAR.
Vorteilhaft ist es, den mittleren Partikeldurchmesser der zur Kombination mit den erfindungsgemäßen Polymerpartikeln verwendeten, modifizierten Polysaccharide kleiner als 20 μm, besonders vorteilhaft kleiner als 15 μm zu wählen.It is advantageous to choose the mean particle diameter of the modified polysaccharides used for combination with the polymer particles according to the invention to be less than 20 μm, particularly advantageously less than 15 μm.
Die Liste der genannten modifizierten Polysaccharide, die mit den erfindungsgemäßen Poiymerpartikeln kombiniert werden können, soll selbstverständlich nicht limitierend sein. Modifizierte Polysaccharide, die im Sinne der vorliegenden Erfindung vorteilhafte Kombinationspartner darstellen, sind auf zahlreichen, an sich bekannten Wegen, sowohl chemischer als auch physikalischer Natur erhältlich. Zur Herstellung solcher Polysac- charide sind auch neue Wege prinzipiell denkbar. Wesentlich dabei ist, daß die modifizierten Polysaccharide amphiphile Eigenschaften zeigen und daß sie nicht verdickend wirken.The list of the modified polysaccharides mentioned, which can be combined with the polymer particles according to the invention, is of course not intended to be limiting. Modified polysaccharides, which are advantageous combination partners for the purposes of the present invention, are obtainable in numerous ways known per se, both chemical and physical. In principle, new ways of producing such polysaccharides are also conceivable. It is essential that the modified polysaccharides show amphiphilic properties and that they do not have a thickening effect.
Vorteilhaft in allen vorgenannten Fällen ist es, die Gesamtkonzentration aller Pigmente größer als 0,1 Gew.-%, besonders vorteilhaft zwischen 0,1 Gew.-% und 30 Gew.-%
bezogen auf das Gesamtgewicht der Zubereitungen zu wählen, wobei die Konzentration an erfindungsgemaßen amphiphilen mikrofeinen Polymerpartikeln - ebenfalls bezogen auf das Gesamtgewicht der Zubereitungen - im Sinne der vorliegenden Erfindung vorzugsweise aus dem Bereich 0,1 Gew -% bis 30 Gew -%, vorteilhaft 0,5 Gew -% bis 10 Gew -% zu wählen istIt is advantageous in all of the aforementioned cases that the total concentration of all pigments is greater than 0.1% by weight, particularly advantageously between 0.1% by weight and 30% by weight. to choose based on the total weight of the preparations, the concentration of amphiphilic microfine polymer particles according to the invention - likewise based on the total weight of the preparations - in the sense of the present invention preferably from the range 0.1% by weight to 30% by weight, advantageously 0, 5% to 10% by weight is to be selected
Die erfindungsgemaßen Pickering-Emulsionen können als Grundlage für kosmetische oder dermatologische Formulierungen dienen Diese können wie üblich zusammengesetzt sein und beispielsweise zur Behandlung und der Pflege der Haut, als Lippenpfle- geprodukt, als Deoprodukt und als Schmink- bzw Abschminkprodukt in der dekorativen Kosmetik oder als Lichtschutzpraparat dienen Zur Anwendung werden die erfindungsgemaßen kosmetischen und dermatologischen Zubereitungen in der für Kosmetika üblichen Weise auf die Haut in ausreichender Menge aufgebrachtThe Pickering emulsions according to the invention can serve as the basis for cosmetic or dermatological formulations. These can be composed as usual and for example for the treatment and care of the skin, as a lip care product, as a demo product and as a make-up or make-up removal product in decorative cosmetics or as a light protection preparation For use, the cosmetic and dermatological preparations according to the invention are applied to the skin in a sufficient amount in the manner customary for cosmetics
Entsprechend können kosmetische oder topische dermatologische Zusammensetzungen im Sinne der vorliegenden Erfindung, je nach ihrem Aufbau, beispielsweise verwendet werden als Hautschutzcreme, Reinigungsmilch, Sonnenschutzlotion, Nahrcreme, Tages- oder Nachtcreme usw Es ist gegebenenfalls möglich und vorteilhaft, die erfindungsgemaßen Zusammensetzungen als Grundlage für pharmazeutische Formulierun- gen zu verwendenAccordingly, cosmetic or topical dermatological compositions in the sense of the present invention, depending on their structure, can be used, for example, as skin protection cream, cleansing milk, sunscreen lotion, nutritional cream, day or night cream, etc. It is possible and advantageous, if appropriate, to use the compositions according to the invention as the basis for pharmaceutical formulations - to use gene
Die erfindungsgemaßen kosmetischen und dermatologischen Zubereitungen können kosmetische Hiifsstoffe enthalten, wie sie üblicherweise in solchen Zubereitungen verwendet werden, z B Konservierungsmittel, Bakterizide, Parfüme, Substanzen zum Ver- hindern des Schäumens, Farbstoffe, Pigmente, die eine färbende Wirkung haben, Ver- dickungsmittel, weichmachende, anfeuchtende und/oder feuchthaltende Substanzen, Fette, Ole, Wachse oder andere übliche Bestandteile einer kosmetischen oder dermatologischen Formulierung wie Alkohole, Polyole, Polymere, Schaumstabilisatoren, Elek- trolyte, organische Losemittel oder SilikonderivateThe cosmetic and dermatological preparations according to the invention can contain cosmetic auxiliaries, as are usually used in such preparations, for example preservatives, bactericides, perfumes, substances for preventing foaming, dyes, pigments which have a coloring effect, thickeners, softening, moisturizing and / or moisturizing substances, fats, oils, waxes or other usual components of a cosmetic or dermatological formulation such as alcohols, polyols, polymers, foam stabilizers, electrolytes, organic solvents or silicone derivatives
Eine erstaunliche Eigenschaft der erfindungsgemaßen Zubereitungen ist, daß diese sehr gute Vehikel für kosmetische oder dermatologische Wirkstoffe in die Haut sind, wobei vorteilhafte Wirkstoffe Antioxidantien sind, welche die Haut vor oxidativer Beanspruchung schützen können
Erfmdungsgemaß enthalten die Zubereitungen vorteilhaft eines oder mehrere Antioxi- dantien Als gunstige aber dennoch fakultativ zu verwendende Antioxidantieπ können alle für kosmetische und/oder dermatologische Anwendungen geeigneten oder ge- brauchlichen Antioxidantien verwendet werden Es ist dabei vorteilhaft, Antioxidantien als einzige Wirkstoffklasse zu verwenden, etwa dann, wenn eine kosmetische oder der- matoiogische Anwendung im Vordergrund steht, wie z B die Bekämpfung der oxidati- ven Beanspruchung der Haut Es ist aber auch gunstig, die erfindungsgemaßen Stiftzubereitungen mit einem Gehalt an einem oder mehreren Antioxidantien zu versehen, wenn die Zubereitungen einem anderen Zweck dienen sollen, z B als Desodorantien oder SonnenschutzmittelAn astonishing property of the preparations according to the invention is that they are very good vehicles for cosmetic or dermatological active ingredients in the skin, advantageous active ingredients being antioxidants which can protect the skin against oxidative stress According to the invention, the preparations advantageously contain one or more antioxidants. All the antioxidants suitable or useful for cosmetic and / or dermatological applications can be used as cheap but nevertheless optional antioxidants. It is advantageous to use antioxidants as the only class of active ingredient, for example then , if a cosmetic or dermatological application is in the foreground, such as combating the oxidative stress on the skin. However, it is also advantageous to provide the stick preparations according to the invention with one or more antioxidants if the preparations are different To serve the purpose, for example as deodorants or sunscreens
Besonders vorteilhaft werden die Antioxidantien gewählt aus der Gruppe bestehend aus Aminosäuren (z B Glycin, Histidin, Tyrosin, Tryptophan) und deren Derivate, Imidazole (z B Urocaninsaure) und deren Derivate, Peptide wie D,L-Carnosιn, D-Carnosin, L-Car- nosin und deren Derivate (z B Anseπn), Carotinoide, Carotine (z B α-Carotin, ß-Carotin, Lycopin) und deren Derivate, Chlorogensaure und deren Derivate, Liponsaure und deren Derivate (z B Dihydroliponsaure), Aurothioglucose, Propylthiouracil und andere Thiole (z B Thioredoxin, Glutathion, Cystein, Cystin, Cystamin und deren Glycosyl- N- Acetyl- Methyl-, Ethyl-, Propyl-, Amyl-, Butyl- und Lauryl-, Palmitoyl-, Oleyl-, γ-ünoleyl-, Cholesteryl- und Giycerylester) sowie deren Salze, Dilaurylthiodipropionat, Distearylthio- dipropionat, Thiodipropionsaure und deren Derivate (Ester, Ether, Peptide, Lipide, Nukleotide Nukleoside und Salze) sowie Sulfoximinverbindungen (z B Buthiomn- sulfoximine, Homocysteinsulfoximm, Buthionmsulfone, Penta-, Hexa-, Heptathionm- sulfoximin) in sehr geringen vertraglichen Dosierungen (z B pmol bis μmol/kg), ferner (Metall)-Chelatoren (z B α-Hydroxyfettsauren, Palmitinsaure, Phytinsaure, Lactoferπn) α-Hydroxysauren (z B Citronensaure, Milchsäure, Apfelsaure), Hummsaure, Gallensaure, Gallenextrakte, Bilirubin, Biliverdin, EDTA, EGTA und deren Derivate, ungesättigte Fettsauren und deren Derivate (z B γ-Linolensaure, Linolsaure, Olsaure), Folsaure und deren Derivate, Ubichinon und Ubichinol und deren Derivate, Vitamin C und Deπvate (z B Ascorbylpaimitat, Mg-Ascorbylphosphat, Ascorbylacetat), Tocopherole und Derivate (z B Vitamin-E-acetat), Vitamin A und Derivate (Vitamin-A-palmitat) sowie Koniferylbenzoat des Benzoeharzes Rutmsaure und deren Derivate, -Glycosylrutin, Ferulasaure Furfurylidenglucitol, Carnosin Butylhydroxytoluol, Butylhydroxyanisol,
Nordihydroguajakharzsäure, Nordihydroguajaretsäure, Trihydroxybutyrophenon, Harnsäure und deren Derivate, Mannose und deren Derivate, Zink und dessen Derivate (z.B. ZnO, ZnSO4), Selen und dessen Derivate (z.B. Selenmethionin), Stilbene und deren Derivate (z.B. Stilbenoxid, Trans-Stilbenoxid) und die erfindungsgemäß geeigneten Deriva- te (Salze, Ester, Ether, Zucker, Nukleotide, Nukleoside, Peptide und Lipide) dieser genannten Wirkstoffe.The antioxidants are particularly advantageously selected from the group consisting of amino acids (eg glycine, histidine, tyrosine, tryptophan) and their derivatives, imidazoles (eg urocanic acid) and their derivatives, peptides such as D, L-carnosine, D-carnosine, L -Carnosine and its derivatives (eg Anseπn), carotenoids, carotenes (eg α-carotene, β-carotene, lycopene) and their derivatives, chlorogenic acid and their derivatives, lipoic acid and its derivatives (eg dihydroliponic acid), aurothioglucose, Propylthiouracil and other thiols (e.g. thioredoxin, glutathione, cysteine, cystine, cystamine and their glycosyl, N, acetyl, methyl, ethyl, propyl, amyl, butyl and lauryl, palmitoyl, oleyl, γ, unoleyl, cholesteryl and glyceryl esters) and their salts, dilauryl thiodipropionate, distearyl thio dipropionate, thiodipropionic acid and their derivatives (esters, ethers, peptides, lipids, nucleotides, nucleosides and salts) as well as sulfoximine compounds (eg buthiomn-sulfoxmsulfone, homocysteine sulfone sulfone, homocysteine sulfone sulfate, homocysteine sulfone sulfate, homocysteine sulfone sulfate, homocysteine sulfone sulfate, homocysteine sulfone sulfate, homocysteine sulfone sulfate, homocysteine sulfone sulfate, homocysteine sulfone sulfate, homocysteine sulfone sulfone, homocysteine sulfone sulfone, homocysteine sulfone sulfone, homocysteine sulfone sulfone, nta-, hexa-, heptathione-sulfoximine) in very low contractual doses (e.g. pmol to μmol / kg), furthermore (metal) chelators (e.g. α-hydroxy fatty acids, palmitic acid, phytic acid, lactoferπn) α-hydroxy acids (e.g. Citric acid, lactic acid, malic acid), humic acid, bile acid, bile extracts, bilirubin, biliverdin, EDTA, EGTA and their derivatives, unsaturated fatty acids and their derivatives (e.g. γ-linolenic acid, linoleic acid, oleic acid), folic acid and its derivatives, ubiquinone and ubiquinone and ubiquinone and ubiquinone and ubiquinone their derivatives, vitamin C and derivatives (e.g. ascorbyl paimitat, Mg ascorbyl phosphate, ascorbyl acetate), tocopherols and derivatives (e.g. vitamin E acetate), vitamin A and derivatives (vitamin A palmitate) and coniferyl benzoate of the benzoic resin rutmate and their Derivatives, -Glycosylrutin, Ferulasaure Furfurylidenglucitol, Carnosin Butylhydroxytoluol, Butylhydroxyanisol, Nordihydroguajakh resin acid, Nordihydroguajaretsäure, trihydroxybutyrophenon, uric acid and its derivatives, mannose and its derivatives, zinc and its derivatives (e.g. ZnO, ZnSO 4 ), selenium and its derivatives (e.g. selenomethionine), stilbenes and their derivatives (e.g. stilbene oxide and trans-stilbene oxide) the derivatives suitable according to the invention (salts, esters, ethers, sugars, nucleotides, nucleosides, peptides and lipids) of these active substances.
Die Menge der vorgenannten Antioxidantien (eine oder mehrere Verbindungen) in den erfindungsgemäßen Zubereitungen beträgt vorzugsweise 0,001 bis 30 Gew.-%, beson- ders bevorzugt 0,05 - 20 Gew.-%, insbesondere 1 - 10 Gew.-%, bezogen auf das Gesamtgewicht der Zubereitung.The amount of the aforementioned antioxidants (one or more compounds) in the preparations according to the invention is preferably 0.001 to 30% by weight, particularly preferably 0.05-20% by weight, in particular 1-10% by weight, based on the total weight of the preparation.
Sofern Vitamin E und/oder dessen Derivate das oder die Antioxidantien darstellen, ist vorteilhaft, deren jeweilige Konzentrationen aus dem Bereich von 0,001 - 10 Gew.-%, bezogen auf das Gesamtgewicht der Formulierung, zu wählen.If vitamin E and / or its derivatives represent the antioxidant (s), it is advantageous to choose their respective concentrations from the range of 0.001-10% by weight, based on the total weight of the formulation.
Sofern Vitamin A, bzw. Vitamin-A-Derivate, bzw. Carotine bzw. deren Derivate das oder die Antioxidantien darstellen, ist vorteilhaft, deren jeweilige Konzentrationen aus dem Bereich von 0,001 - 10 Gew.-%, bezogen auf das Gesamtgewicht der Formulierung, zu wählen.If vitamin A or vitamin A derivatives or carotenes or their derivatives represent the antioxidant or antioxidants, it is advantageous to use their respective concentrations in the range from 0.001-10% by weight, based on the total weight of the formulation, to choose.
Erfindungsgemäß können die Wirkstoffe (eine oder mehrere Verbindungen) auch sehr vorteilhaft gewählt werden aus der Gruppe der lipophilen Wirkstoffe, insbesondere aus folgender Gruppe:According to the invention, the active ingredients (one or more compounds) can also be selected very advantageously from the group of lipophilic active ingredients, in particular from the following group:
Acetylsalicylsäure, Atropin, Azulen, Hydrocortison und dessen Derivaten, z.B. Hydrocor- tison-17-valerat, Vitamine, z.B. Ascorbinsäure und deren Derivate, Vitamine der B- und D-Reihe, sehr günstig das Vitamin Bi, das Vitamin Bι2 das Vitamin DL aber auch Bisabolol, ungesättigte Fettsäuren, namentlich die essentiellen Fettsäuren (oft auch Vi- tamin F genannt), insbesondere die gamma-Linolensäure, Ölsäure, Eicosapentaensäu- re, Docosahexaensäure und deren Derivate, Chloramphenicol, Coffein, Prostaglandine, Thymol, Campher, Extrakte oder andere Produkte pflanzlicher und tierischer Herkunft, z.B. Nachtkerzenöl, Borretschöl oder Johannisbeerkernöl, Fischöle, Lebertran aber auch Ceramide und ceramidähnliche Verbindungen und so weiter.
Vorteilhaft ist es auch, die Wirkstoffe aus der Gruppe der rückfettenden Substanzen zu wählen, beispielsweise Purcellinöl, Eucerit und Neocerit .Acetylsalicylic acid, atropine, azulene, hydrocortisone and its derivatives, for example hydrocortisone 17-valerate, vitamins, for example ascorbic acid and its derivatives, vitamins of the B and D series, very cheap the vitamin Bi, the vitamin Bι 2 the vitamin D. L but also bisabolol, unsaturated fatty acids, especially the essential fatty acids (often also called vitamin F), especially gamma-linolenic acid, oleic acid, eicosapentaenoic acid, docosahexaenoic acid and its derivatives, chloramphenicol, caffeine, prostaglandins, thymol, camphor, extracts or other products of vegetable and animal origin, for example evening primrose oil, borage oil or currant seed oil, fish oils, cod liver oil but also ceramides and ceramide-like compounds and so on. It is also advantageous to select the active substances from the group of refatting substances, for example purcellin oil, Eucerit and Neocerit.
Die Liste der genannten Wirkstoffe bzw. Wirkstoff kombinationen, die in den erfindungsgemäßen Pickering-Emulsionen verwendet werden können, soll selbstverständlich nicht limitierend sein.The list of the active substances or combinations of active substances mentioned which can be used in the Pickering emulsions according to the invention is of course not intended to be limiting.
Günstig sind auch kosmetische und dermatologische Zubereitungen, die in der Form eines Sonnenschutzmittels vorliegen. Vorzugsweise enthalten diese mindestens eine UV-A-Filtersubstanz und/oder mindestens eine UV-B-Filtersubstanz und/oder mindestens ein weiteres anorganisches Pigment aus der Gruppe der Oxide des Eisens, Zirkoniums, Siliciums, Mangans, Aluminiums, Cers und Mischungen davon sowie Abwandlungen, bei denen die Oxide die aktiven Agentien sind.Cosmetic and dermatological preparations in the form of a sunscreen are also favorable. These preferably contain at least one UV-A filter substance and / or at least one UV-B filter substance and / or at least one further inorganic pigment from the group of the oxides of iron, zirconium, silicon, manganese, aluminum, cerium and mixtures thereof, and modifications where the oxides are the active agents.
Es ist aber auch vorteilhaft im Sinne der vorliegenden Erfindungen, solche kosmetischen und dermatologischen Zubereitungen zu erstellen, deren hauptsächlicher Zweck nicht der Schutz vor Sonnenlicht ist, die aber dennoch einen Gehalt an UV-Schutzsubstanzen enthalten. So werden beispielsweise in Tagescremes gewöhnlich UV-A- bzw. UV-B-Filtersubstanzen eingearbeitet.However, it is also advantageous in the sense of the present inventions to create cosmetic and dermatological preparations whose main purpose is not protection against sunlight, but which nevertheless contain UV protection substances. For example, UV-A or UV-B filter substances are usually incorporated into day creams.
Vorteilhaft können erfindungsgemäße Zubereitungen Substanzen enthalten, die UV- Strahlung im UV-B-Bereich absorbieren, wobei die Gesamtmenge der Filtersubstanzen z. B. 0,1 Gew.-% bis 30 Gew.-%, vorzugsweise 0,5 bis 15 Gew.-%, bezogen auf das Gesamtgewicht der Zubereitungen, um kosmetische Zubereitungen zur Verfügung zu stellen, die das Haar bzw. die Haut vor dem gesamten Bereich der ultravioletten Strahlung schützen.Preparations according to the invention can advantageously contain substances which absorb UV radiation in the UV-B range, the total amount of filter substances, for. B. 0.1 wt .-% to 30 wt .-%, preferably 0.5 to 15 wt .-%, based on the total weight of the preparations to provide cosmetic preparations that the hair or the skin before protect the entire range of ultraviolet radiation.
Enthalten die erfindungsgemäßen Emulsionen UV-B-Filtersubstanzen, können diese öl- löslich oder wasserlöslich sein. Erfindungsgemäß vorteilhafte öllösliche UV-B-Filter sind z.B.:If the emulsions according to the invention contain UV-B filter substances, they can be oil-soluble or water-soluble. Oil-soluble UV-B filters which are advantageous according to the invention are, for example:
. 3-Benzylidencampher-Derivate, vorzugsweise 3-(4-Methylbenzyliden)campher, 3- Benzylidencampher;
. 4-Amιnobenzoesaure-Deπvate, vorzugsweise 4-(Dιmethylamιno)-benzoesaure(2- ethylhexyl)ester, 4-(Dιmethylamιno)benzoesaureamylester,, 3-benzylidene camphor derivatives, preferably 3- (4-methylbenzylidene) camphor, 3-benzylidene camphor; , 4-aminobenzoic acid, preferably 4- (dimethylamino) benzoic acid (2-ethylhexyl) ester, 4- (dimethylamino) amyl benzoate,
. Ester der Zimtsaure, vorzugsweise 4-Methoxyzιmtsaure(2-ethylhexyl)ester, 4-Meth- oxyzimtsaureisopentylester, • Ester der Salicylsaure, vorzugsweise Salιcylsaure(2-ethylhexyl)ester, Salιcylsaure(4- ιsopropylbenzyl)ester, Salicylsaurehomomenthylester,. Esters of cinnamic acid, preferably 4-methoxycinnamate (2-ethylhexyl) ester, 4-methoxycinnamate isopentyl ester, • esters of salicylic acid, preferably salicyl acid (2-ethylhexyl) ester, salicyl acid (4-isopropylbenzyl) ester, salicyl ester,
. Derivate des Benzophenons, vorzugsweise 2-Hydroxy-4-methoxybenzophenon, 2- Hydroxy-4-methoxy-4'-methylbenzophenon, 2,2'-Dιhydroxy-4-methoxybenzophenon,. Derivatives of benzophenone, preferably 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxy-4'-methylbenzophenone, 2,2'-dihydroxy-4-methoxybenzophenone,
. Ester der Benzalmalonsaure, vorzugsweise 4-Methoxybenzalmalonsauredι(2-ethylhe- xyl)ester,. Esters of benzalmalonic acid, preferably 4-methoxybenzalmalonic acid (2-ethylhexyl) ester,
. hinsichtlich der C3-Achse des Tnazingrundkorpers symmetrisch oder unsymmetrisch substituierte Tπazindeπvate, vorzugsweise 4,4',4"-(1 ,3,5-Trιazιn-2,4,6-tπyltπιmιno)- tπs-benzoesaure-trιs(2-ethylhexylester) (symmetrisch) sowie 2,4-Bιs-{[4-(2-Ethyl- hexyloxy)-2-hydroxy]-phenyl}-6-(4-methoxyphenyl)-1 ,3,5-tπazιn, 2,4-Bιs-{[4-(3- sulfonato)-2-hydroxy-propyioxy)-2-hydroxy]-phenyl}-6-(4-methoxyphenyl)-1 ,3,5-trιazιn, Tπazindenπvate symmetrically or asymmetrically substituted with respect to the C 3 axis of the basic tnazine body, preferably 4,4 ', 4 "- (1, 3,5-trιazιn-2,4,6-tπyltπιmιno) - tπs-benzoic acid trιs (2-ethylhexyl ester ) (symmetrical) and 2,4-Bιs - {[4- (2-ethylhexyloxy) -2-hydroxy] phenyl} -6- (4-methoxyphenyl) -1, 3,5-tπazιn, 2,4 -Bιs - {[4- (3-sulfonato) -2-hydroxy-propyioxy) -2-hydroxy] phenyl} -6- (4-methoxyphenyl) -1, 3,5-trιazιn
Natriumsalz, 2,4-Bιs-{[4-(3-(2-Propyloxy)-2-hydroxy-propyloxy)-2-hydroxy]-phenyl}-6-Sodium salt, 2,4-bιs - {[4- (3- (2-propyloxy) -2-hydroxypropyloxy) -2-hydroxy] phenyl} -6-
(4-methoxyphenyl)-1,3,5-trιazιn, 2,4-Bιs-{[4-(2-ethyl-hexyloxy)-2-hydroxy]-phenyl}-6-(4-methoxyphenyl) -1,3,5-trιazιn, 2,4-Bιs - {[4- (2-ethylhexyloxy) -2-hydroxy] phenyl} -6-
[4-(2-methoxyethyl-carboxyl)-phenylamιno]-1 ,3,5-tπazιn, 2,4-Bιs-{[4-(3-(2-propyloxy)-[4- (2-methoxyethyl-carboxyl) phenylamine] -1, 3,5-tπazιn, 2,4-Bιs - {[4- (3- (2-propyloxy) -
2-hydroxy-propyloxy)-2-hydroxy]-phenyl}-6-[4-(2-ethyl-carboxyl)-phenylamιno]-1 ,3,5- tnazin, 2,4-Bιs-{[4-(2-ethyl-hexyloxy)-2-hydroxy]-phenyl}-6-(1-methyl-pyrrol-2-yl)-1 ,3,5- tπazm, 2,4-Bιs-{[4-trιs(tπmethyisιloxy-sιlylpropyloxy)-2-hydroxy]-phenyl}-6-(4-methoxy- phenyl)-1 ,3,5-tπazιn, 2,4-Bιs-{[4-(2"-methylpropenyloxy)-2-hydroxy]-phenyl}-6-(4- methoxyphenyl)-1 ,3,5-tπazιn, 2,4-Bιs-{[4-(1', 1', 1', 3', 5' ,5' ,5'-Heptamethylsιloxy-2- methyl-propyloxy)-2-hydroxy]-phenyl}-6-(4-methoxyphenyl)-1,3,5-trιazιn (unsymme- tπsch),2-hydroxy-propyloxy) -2-hydroxy] phenyl} -6- [4- (2-ethyl-carboxyl) phenylamine] -1, 3,5-tnazine, 2,4-bιs - {[4- ( 2-ethyl-hexyloxy) -2-hydroxy] phenyl} -6- (1-methyl-pyrrol-2-yl) -1, 3,5-tπazm, 2,4-Bιs - {[4-trιs (tπmethyisιloxy -sιlylpropyloxy) -2-hydroxy] -phenyl} -6- (4-methoxy-phenyl) -1, 3,5-tπazιn, 2,4-Bιs - {[4- (2 "-methylpropenyloxy) -2-hydroxy ] -phenyl} -6- (4-methoxyphenyl) -1, 3,5-tπazιn, 2,4-Bιs - {[4- (1 ', 1', 1 ', 3', 5 ', 5', 5'-heptamethylsιloxy-2-methyl-propyloxy) -2-hydroxy] phenyl} -6- (4-methoxyphenyl) -1,3,5-trιazιn (asymmetrical),
. Benzotπazoldeπvate, vorzugsweise 2,2'-Methylen-bιs-(6-(2H-benzotπazol-2-yl)-4- (1 , 1 ,3,3-tetramethylbutyl)-phenol). Benzotπazoldeπvate, preferably 2,2'-methylene-bιs- (6- (2H-benzotπazol-2-yl) -4- (1, 1, 3,3-tetramethylbutyl) phenol)
. sowie an Polymere gebundene UV-Filter. as well as UV filters bound to polymers
Vorteilhafte wasserlösliche UV-B-Filtersubstanzen sind z BAdvantageous water-soluble UV-B filter substances are, for example
. Salze der 2-Phenylbenzιmιdazol-5-sulfonsaure, wie ihr Natrium-, Kalium- oder ihr Tπ- ethanolammonium-Salz, sowie die Sulfonsaure selbst,
. Sulfonsäure-Derivate des 3-Benzylidencamphers, wie z.B. 4-(2-Oxo-3-bornylidenme- thyl)benzolsulfonsäure, 2-Methyl-5-(2-oxo-3-bornylidenmethyl)sulfonsäure und deren Salze., Salts of 2-phenylbenzιmιdazol-5-sulfonic acid, such as its sodium, potassium or Tπ-ethanolammonium salt, and the sulfonic acid itself, , Sulfonic acid derivatives of 3-benzylidene camphor, such as 4- (2-oxo-3-bornylidene methyl) benzenesulfonic acid, 2-methyl-5- (2-oxo-3-bornylidene methyl) sulfonic acid and their salts.
Die Liste der genannten UV-B-Filter, die in den erfindungsgemäßen Pickering-Emulsionen verwendet werden können, soll selbstverständlich nicht limitierend sein.The list of the UV-B filters mentioned, which can be used in the Pickering emulsions according to the invention, is of course not intended to be limiting.
Es kann auch von Vorteil sein, in erfindungsgemäßen Pickering-Emulsionen UV-A-Filter zu verwenden, die bisher üblicherweise in kosmetischen Zubereitungen enthalten sind. Bei diesen Substanzen handelt es sich vorzugsweise um Derivate des Dibenzoyl- methans, insbesondere um 1-(4'-tert.Butylphenyl)-3-(4'-methoxyphenyl)propan-1 ,3-dion und um 1-Phenyl-3-(4'-isopropylphenyl)propan-1 ,3-dion.It can also be advantageous to use UV-A filters in Pickering emulsions according to the invention which have hitherto usually been contained in cosmetic preparations. These substances are preferably derivatives of dibenzoyl methane, in particular 1- (4'-tert-butylphenyl) -3- (4'-methoxyphenyl) propane-1, 3-dione and 1-phenyl-3- (4'-isopropylphenyl) propane-1,3-dione.
Weitere vorteilhafte UV-A-Filtersubstanzen sind die Phenylen-1 ,4-bis-(2-benzi- midazyl)-3,3'-5,5'-tetrasulfonsäure:Other advantageous UV-A filter substances are phenylene-1,4-bis (2-benzimidazyl) -3,3'-5,5'-tetrasulfonic acid:
und ihre Salze, besonders die entsprechenden Natrium-, Kalium- oder Triethanol- ammonium-Salze, insbesondere das Phenylen-1 ,4-bis-(2-benzimidazyl)-3,3'-5,5'- tetrasulfonsäure-bis-natriumsalz: and their salts, especially the corresponding sodium, potassium or triethanolammonium salts, especially the phenylene-1,4-bis (2-benzimidazyl) -3,3'-5,5'-tetrasulfonic acid bis-sodium salt :
sowie das 1 ,4-di(2-oxo-10-Sulfo-3-bornylidenmethyl)-Benzol und dessen Salze (besonders die entprechenden 10-Sulfato-verbindungen, insbesondere das entsprechende Natrium-, Kalium- oder Triethanolammonium-Salz), das auch als Ben- zol-1 ,4-di(2-oxo-3-bornylidenmethyl-10-Sulfonsäure) bezeichnet wird und sich durch die folgende Struktur auszeichnet:
as well as the 1,4-di (2-oxo-10-sulfo-3-bornylidenemethyl) benzene and its salts (especially the corresponding 10-sulfato compounds, especially the corresponding sodium, potassium or triethanolammonium salt), the is also referred to as benzene-1,4-di (2-oxo-3-bornylidenemethyl-10-sulfonic acid) and is characterized by the following structure:
Vorteilhafte UV-Filtersubstanzen sind ferner sogenannte Breitbandfilter, d.h. Filtersubstanzen, die sowohl UV-A- als auch UV-B-Strahlung absorbieren.Advantageous UV filter substances are also so-called broadband filters, i.e. Filter substances that absorb both UV-A and UV-B radiation.
Ein vorteilhaft zu verwendender Breitbandfilter ist beispielsweise das Ethylhexyl-2- cyano-3,3-diphenylacrylat (Octocrylen), welches von BASF unter der Bezeichnung Uvinul® N 539 erhältlich ist und sich durch folgende Struktur auszeichnet:An example of a broadband filter which can be used advantageously is ethylhexyl-2-cyano-3,3-diphenyl acrylate (octocrylene), which is available from BASF under the name Uvinul ® N 539 and is characterized by the following structure:
Auch Zubereitungen, die UV-A-Filter bzw. sogenannte Breitbandfilter enthalten, sind Gegenstand der Erfindung. Es können die für die UV-B-Kombination verwendeten Mengen eingesetzt werden.Preparations which contain UV-A filters or so-called broadband filters are also the subject of the invention. The quantities used for the UV-B combination can be used.
Vorteilhaft können erfindungsgemäße Zubereitungen außerdem als Grundlage für kosmetische Desodorantien bzw. Antitranspirantien eingesetzt werden, so daß die vorliegende Erfindung in einer besonderen Ausführungsform Pickering-Emulsionen als Grundlage für kosmetische Desodorantien betrifft.Preparations according to the invention can also advantageously be used as the basis for cosmetic deodorants or antiperspirants, so that in a particular embodiment the present invention relates to Pickering emulsions as the basis for cosmetic deodorants.
Kosmetische Desodorantien dienen dazu, Körpergeruch zu beseitigen, der entsteht, wenn der an sich geruchlose frische Schweiß durch Mikroorganismen zersetzt wird. Den üblichen kosmetischen Desodorantien liegen unterschiedliche Wirkprinzipien zugrunde.
In sogenannten Antitranspirantien kann durch Adstringentien - vorwiegend Aluminiumsalze wie Aluminiumhydroxychlorid (Aluchlorhydrat) - die Bildung des Schweißes reduziert werden.Cosmetic deodorants are used to eliminate body odor that arises when the fresh, odorless sweat is decomposed by microorganisms. The usual cosmetic deodorants are based on different active principles. In so-called antiperspirants, astringents - primarily aluminum salts such as aluminum hydroxychloride (aluminum chlorohydrate) - can reduce the formation of sweat.
Durch die Verwendung antimikrobieller Stoffe in kosmetischen Desodorantien kann die Bakterienflora auf der Haut reduziert werden. Dabei sollten im Idealfalle nur die Geruch verursachenden Mikroorganismen wirksam reduziert werden. Der Schweißfluß selbst wird dadurch nicht beeinflußt, im Idealfalle wird nur die mikrobielle Zersetzung des Schweißes zeitweilig gestoppt.The use of antimicrobial substances in cosmetic deodorants can reduce the bacterial flora on the skin. Ideally, only the odor-causing microorganisms should be effectively reduced. The sweat flow itself is not affected by this, in the ideal case only the microbial decomposition of the sweat is temporarily stopped.
Auch die Kombination von Adstringentien mit antimikrobiell wirksamen Stoffen in ein und derselben Zusammensetzung ist gebräuchlich.The combination of astringents with antimicrobial substances in one and the same composition is also common.
Alle für Desodorantien bzw. Antitranspirantien gängigen Wirkstoffe können vorteilhaft genutzt werden, beispielsweise Geruchsüberdecker wie die gängigen Parfümbestandteile, Geruchsabsorber, beispielsweise die in der Patentoffenlegungsschrift DE-P 40 09 347 beschriebenen Schichtsilikate, von diesen insbesondere Montmorillonit, Kaolinit, llit, Beidellit, Nontronit, Saponit, Hectorit, Bentonit, Smectit, ferner beispielsweise Zinksalze der Ricinolsäure. Keimhemmende Mittel sind ebenfalls geeignet, in die erfindungsgemäßen W/O-Emulsionsstifte eingearbeitet zu werden. Vorteilhafte Substanzen sind zum Beispiel 2,4,4'-Trichlor-2'-hdroxydiphenylether (Irgasan), 1 ,6-Di-(4-chiorphenylbi- guanido)-hexan (Chlorhexidin), 3,4,4'-Trichlorcarbanilid, quatemäre Ammoniumverbindungen, Nelkenöl, Minzöl, Thymianöl, Triethylcitrat, Farnesol (3,7,11-Trimethyl-2,6, 10- dodecatrien-1-ol) sowie die in den Patentoffenlegungsschriften DE-37 40 186, DE- 39 38 140, DE-42 04 321 , DE-42 29 707, DE-43 09 372, DE-44 11 664, DE-195 41 967, DE-195 43 695, DE-195 43 696, DE-195 47 160, DE-196 02 108, DE-196 02 110, DE- 196 02 111 , DE-196 31 003, DE-196 31 004 und DE-196 34 019 und den Patentschriften DE-42 29 737, DE-42 37 081 , DE-43 24 219, DE-44 29 467, DE-44 23 410 und DE- 195 16 705 beschriebenen Wirkstoffe bzw. Wirkstoffkombinationen. Auch Natrium- hydrogencarbonat ist vorteilhaft zu verwenden.
Die Liste der genannten Wirkstoffe bzw. Wirkstoffkombinationen, die in den erfindungsgemäßen Pickering-Emulsionen verwendet werden können, soll selbstverständlich nicht limitierend sein.All active ingredients for deodorants or antiperspirants can be used advantageously, for example odor maskers such as the common perfume components, odor absorbers, for example the layered silicates described in patent application DE-P 40 09 347, of which in particular montmorillonite, kaolinite, llite, beidellite, nontronite, saponite , Hectorite, bentonite, smectite, furthermore, for example, zinc salts of ricinoleic acid. Germ-inhibiting agents are also suitable for being incorporated into the W / O emulsion sticks according to the invention. Advantageous substances are, for example, 2,4,4'-trichloro-2'-hydroxydiphenyl ether (irgasane), 1,6-di- (4-chlorophenylbiganido) hexane (chlorhexidine), 3,4,4'-trichlorocarbanilide, quaternary ammonium compounds, clove oil, mint oil, thyme oil, triethyl citrate, farnesol (3,7,11-trimethyl-2,6, 10-dodecatrien-1-ol) and those described in patent publications DE-37 40 186, DE-39 38 140, DE-42 04 321, DE-42 29 707, DE-43 09 372, DE-44 11 664, DE-195 41 967, DE-195 43 695, DE-195 43 696, DE-195 47 160, DE- 196 02 108, DE-196 02 110, DE-196 02 111, DE-196 31 003, DE-196 31 004 and DE-196 34 019 and the patents DE-42 29 737, DE-42 37 081, DE- 43 24 219, DE-44 29 467, DE-44 23 410 and DE-195 16 705 described active ingredients or combinations of active ingredients. Sodium hydrogen carbonate can also be used advantageously. The list of the active substances or combinations of active substances mentioned which can be used in the Pickering emulsions according to the invention is of course not intended to be limiting.
Die erfindungsgemäßen kosmetischen Desodorantien können in Form von aus normalen Behältern auftragbaren wasserhaltigen, kosmetischen Zubereitungen vorliegen.The cosmetic deodorants according to the invention can be in the form of water-containing cosmetic preparations which can be applied from normal containers.
Die Menge der Antitranspiranswirkstoffe oder Desodorantien (eine oder mehrere Verbindungen) in den Zubereitungen beträgt vorzugsweise 0,01 bis 30 Gew.-%, besonders bevorzugt 0,1 - 20 Gew.-%, insbesondere 1 - 10 Gew.-%, bezogen auf das Gesamtgewicht der Zubereitung.The amount of the antiperspirant active ingredients or deodorants (one or more compounds) in the preparations is preferably 0.01 to 30% by weight, particularly preferably 0.1-20% by weight, in particular 1-10% by weight, based on the total weight of the preparation.
Die erfindungsgemäßen Stifte sind ferner hervorragende Vehikel für dermatologische Wirkstoffe. Insbesondere eignen sie sich als Träger für gegen Akne wirksame Substan- zen. Akne ist eine Hauterkrankung mit verschiedenen Formen und Ursachen, gekennzeichnet durch nicht entzündliche und entzündliche Knötchen, ausgehend von verstopften Haarfollikeln (Komedonen), die zur Pustel-, Abszeß- und Narbenbildung führen kann. Am häufigsten ist die Acne vulgaris, die vorwiegend in der Pubertät auftritt. Ursächliche Bedingungen für die Acne vulgaris sind die Verhornung und Verstopfung der Haarfollikel-Mündung, die vom Blutspiegel der männlichen Sexualhormone abhängige Taigproduktion und die Produktion freier Fettsäuren und gewebeschädigender Enzyme durch Bakterien {Propionibacterium acnes).The pens according to the invention are also excellent vehicles for dermatological active ingredients. They are particularly suitable as carriers for substances active against acne. Acne is a skin disease with various forms and causes, characterized by non-inflammatory and inflammatory nodules, starting from blocked hair follicles (comedones), which can lead to pustules, abscesses and scars. The most common is acne vulgaris, which mainly occurs during puberty. Causal conditions for acne vulgaris are cornification and constipation of the hair follicle mouth, the production of taig depending on the blood level of the male sex hormones and the production of free fatty acids and tissue-damaging enzymes by bacteria {Propionibacterium acnes).
Daher ist es vorteilhaft, den erfindungsgemäßen Zubereitungen gegen Akne wirksame Substanzen zuzugeben, die beispielsweise gegen Propionibacterium acnes wirksam sind (etwa solche, die in DE-OS 42 29 707, DE-OS 43 05 069, DE-OS 43 07 976, DE- OS 43 37 711 , DE-OS 43 29 379 beschrieben werden), aber auch andere gegen Akne wirksame Substanzen, beispielsweise all-trans-Retinsäure, 13-cis-Retinsäure und verwandte Stoffe) oder antientzündliche Wirkstoffe, beispielsweise Batylalkohol (α-Octa- decylglycerylether), Selachylalkohol (α-9-Octadecenylgiycerylether), Chimylalkohol (α- Hexadecylglycerylether) und/oder Bisabolol sowie Antibiotika und/oder Keratolytika.
Keratolytika sind Stoffe, die verhornte Haut (wie z. B. Warzen, Hühneraugen, Schwielen und dergleichen mehr) erweichen, damit sich diese leichter entfernen läßt oder damit sie abfällt bzw. sich auflöst.It is therefore advantageous to add substances which are active against acne to the preparations according to the invention and are active, for example, against Propionibacterium acnes (for example those described in DE-OS 42 29 707, DE-OS 43 05 069, DE-OS 43 07 976, DE- OS 43 37 711, DE-OS 43 29 379), but also other substances active against acne, for example all-trans-retinoic acid, 13-cis-retinoic acid and related substances) or anti-inflammatory agents, for example batyl alcohol (α-octa- decylglyceryl ether), selachyl alcohol (α-9-octadecenylglyceryl ether), chimyl alcohol (α-hexadecylglyceryl ether) and / or bisabolol as well as antibiotics and / or keratolytics. Keratolytics are substances that soften horny skin (such as warts, corns, calluses and the like) so that they can be removed more easily, so that they fall off or dissolve.
Alle gängigen gegen Akne wirksamen Substanzen können vorteilhaft genutzt werden, insbesondere Benzoylperoxid, Bituminosulfonate (Ammonium-, Natrium- und Calcium- Salze von Schieferöl-Sulfonsäuren), Salicylsäure (2-Hydroxybenzoesäure), Miconazol (1-[2-(2,4-Dichlorbenzyloxy)-2-(2,4-dichlorphenyl)-ethyl]-imidazol) und Derivate, Adapalen (6-[3-(1-Adamantyl)-4-methoxyphenyl]-2-naphthoesäure), Azelainsäure (Nonandi- säure), Mesulfen (2,7-Dimethylthianthren, C1 Hι2S2) sowie Aluminiumoxid, Zinkoxid und/oder feinverteilter Schwefel.All common acne-active substances can be used to advantage, especially benzoyl peroxide, bituminosulfonates (ammonium, sodium and calcium salts of shale oil sulfonic acids), salicylic acid (2-hydroxybenzoic acid), miconazole (1- [2- (2,4- Dichlorobenzyloxy) -2- (2,4-dichlorophenyl) ethyl] imidazole) and derivatives, adapalene (6- [3- (1-adamantyl) -4-methoxyphenyl] -2-naphthoic acid), azelaic acid (nonandioic acid) , Mesulfen (2,7-dimethylthianthrene, C 1 Hι 2 S 2 ) and aluminum oxide, zinc oxide and / or finely divided sulfur.
Die Menge der Antiaknemittel (eine oder mehrere Verbindungen) in den Zubereitungen beträgt vorzugsweise 0,01 bis 30 Gew.-%, besonders bevorzugt 0,1 - 20 Gew.-%, ins- besondere 1 - 10 Gew.-%, bezogen auf das Gesamtgewicht der Zubereitung.The amount of the anti-acne agent (one or more compounds) in the preparations is preferably 0.01 to 30% by weight, particularly preferably 0.1-20% by weight, in particular 1-10% by weight, based on the total weight of the preparation.
Die nachfolgenden Beispiele sollen die vorliegende Erfindung verdeutlichen, ohne sie einzuschränken. Die Zahlenwerte in den Beispielen bedeuten Gewichtsprozente, bezogen auf das Gesamtgewicht der jeweiligen Zubereitungen.
The following examples are intended to illustrate the present invention without restricting it. The numerical values in the examples mean percentages by weight, based on the total weight of the respective preparations.
Beispiele:Examples:
Claims
1. Kosmetische oder dermatologische Zubereitungen, die feindisperse Systeme vom Typ Öl-in-Wasser oder Wasser-in-ÖI darstellen, enthaltend 1. eine Olphase,1. Cosmetic or dermatological preparations which are finely dispersed systems of the oil-in-water or water-in-oil type, comprising 1. an oil phase,
2. eine Wasserphase,2. a water phase,
3. mindestens eine Sorte von mikrofeinen Polymerpartikeln, welche3. at least one type of microfine polymer particles, which
(a) in der Zubereitung in Form von Feststoffen vorliegen und welche(a) are present in the preparation in the form of solids and which
(b) sowohl hydrophile als auch lipophile Eigenschaften zeigen, welche also amphiphilen Charakter besitzen und sowohl in Wasser als auch in Öl disper- gierbar sind und(b) show both hydrophilic and lipophilic properties, which therefore have amphiphilic character and are dispersible in both water and oil, and
4. höchstens 0,5 Gew. % eines oder mehrerer Emulgatoren.4. at most 0.5% by weight of one or more emulsifiers.
2. Zubereitungen nach Anspruch 1 , dadurch gekennzeichnet, daß sie emulgatorfrei sind.2. Preparations according to claim 1, characterized in that they are emulsifier-free.
3. Zubereitungen nach einem der vorhergehenden Ansprüche, dadurch gekennzeichnet, daß weitere kosmetische oder pharmazeutische Hilfs-, Zusatz- und/oder Wirkstoffe enthalten sind.3. Preparations according to one of the preceding claims, characterized in that further cosmetic or pharmaceutical auxiliaries, additives and / or active ingredients are included.
4. Zubereitungen nach einem der vorhergehenden Ansprüche, dadurch gekennzeichnet, daß der Gehalt an einem oder mehreren mikrofeinen Polymerpartikeln zwischen 0,1 Gew.-% und 30 Gew.-% ist, bezogen auf das Gesamtgewicht der Zubereitungen.4. Preparations according to one of the preceding claims, characterized in that the content of one or more microfine polymer particles is between 0.1 wt .-% and 30 wt .-%, based on the total weight of the preparations.
5. Zubereitungen nach einem der vorhergehenden Ansprüche, dadurch gekennzeichnet, daß der mittlere Partikeldurchmesser der verwendeten mikrofeinen Polymerpartikel kleiner als 00 μm, besonders vorteilhaft kleiner als 50 μm ist.5. Preparations according to one of the preceding claims, characterized in that the average particle diameter of the microfine polymer particles used is less than 00 microns, particularly advantageously less than 50 microns.
6. Zubereitungen nach einem der vorhergehenden Ansprüche, dadurch gekennzeichnet, daß neben mikrofeinen Polymeφartikeln weitere amphiphile Pigmente enthalten sind, insbesondere Bornitrid und/oder modifizierte Polysaccharide und/oder mikronisierte, anorganische Pigmente, die gewählt werden aus der Gruppe der amphiphilen Metalloxide, insbesondere aus der Gruppe Titandioxid, Zinkoxid,
Eisenoxide bzw. Eisenmischoxide, Siliciumdioxid bzw. Silicate, wobei diese Pigmente sowohl einzeln als auch im Gemisch vorliegen können.6. Preparations according to one of the preceding claims, characterized in that, in addition to microfine polymeφarticles, further amphiphilic pigments are contained, in particular boron nitride and / or modified polysaccharides and / or micronized, inorganic pigments which are selected from the group of amphiphilic metal oxides, in particular from the Group titanium dioxide, zinc oxide, Iron oxides or mixed iron oxides, silicon dioxide or silicates, where these pigments can be present either individually or in a mixture.
7. Zubereitungen nach einem der vorhergehenden Ansprüche, enthaltend einen oder mehrere Zusatz- oder Wirkstoffe, gewählt aus der Gruppe der Antioxidantien und/oder UV-Schutzmittel.7. Preparations according to one of the preceding claims, containing one or more additives or active ingredients selected from the group of antioxidants and / or UV protection agents.
8. Zubereitungen nach einem der vorhergehenden Ansprüche, enthaltend einen oder mehrere Zusatz- oder Wirkstoffe, gewählt aus der Gruppe der Adstringentien und/oder antimikrobiell wirksamen Stoffe und/oder gegen Akne wirksamen Stoffe.
8. Preparations according to one of the preceding claims, containing one or more additives or active substances selected from the group of astringents and / or antimicrobial substances and / or substances active against acne.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19834819A DE19834819A1 (en) | 1998-08-01 | 1998-08-01 | Emulsifier-free finely dispersed systems of the oil-in-water and water-in-oil type |
| DE19834819 | 1998-08-01 | ||
| PCT/EP1999/005242 WO2000007548A1 (en) | 1998-08-01 | 1999-07-22 | Finely dispersed emulsifier-free systems of the oil-in-water and water-in-oil type |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP1100431A1 true EP1100431A1 (en) | 2001-05-23 |
Family
ID=7876168
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP99936590A Withdrawn EP1100431A1 (en) | 1998-08-01 | 1999-07-22 | Finely dispersed emulsifier-free systems of the oil-in-water and water-in-oil type |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US6620407B1 (en) |
| EP (1) | EP1100431A1 (en) |
| JP (1) | JP2002522363A (en) |
| DE (1) | DE19834819A1 (en) |
| WO (1) | WO2000007548A1 (en) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19834819A1 (en) | 1998-08-01 | 2000-02-03 | Beiersdorf Ag | Emulsifier-free finely dispersed systems of the oil-in-water and water-in-oil type |
| DE19834821A1 (en) * | 1998-08-01 | 2000-02-03 | Beiersdorf Ag | Emulsifier-free finely dispersed systems of the oil-in-water and water-in-oil type |
| DE19842786A1 (en) * | 1998-09-18 | 2000-03-23 | Beiersdorf Ag | Pickering emulsions useful as bases for cosmetic or dermatological compositions, containing low viscosity oil to improve feeling and tolerance of skin |
| DE19923645A1 (en) * | 1999-05-22 | 2000-11-23 | Beiersdorf Ag | Cosmetic or dermatological photoprotective preparations containing boron nitride and benzotriazole and the use of boron nitride to improve the skin feel of preparations which are distinguished by a content of UV filter substances which have the structural motif of the benzotriazole |
| FR2822376B1 (en) * | 2001-03-23 | 2004-06-11 | Oreal | USE OF POLYAMIDE PARTICLES AS ANTI-IRRITANT AGENT IN A COSMETIC OR DERMATOLOGICAL COMPOSITION |
| JP4728517B2 (en) * | 2001-06-29 | 2011-07-20 | 株式会社 資生堂 | Topical skin preparation |
| DE10161170A1 (en) * | 2001-12-13 | 2003-06-18 | Beiersdorf Ag | lipstick |
| US7001580B2 (en) * | 2002-12-31 | 2006-02-21 | 3M Innovative Properties Company | Emulsions including surface-modified organic molecules |
| US20050238680A1 (en) | 2004-04-21 | 2005-10-27 | Qing Stella | Personal care compositions that deposit hydrophilic benefit agents |
| US20050238595A1 (en) * | 2004-04-21 | 2005-10-27 | Qing Stella | Personal care compositions that deposit sunless tanning benefit agents |
| US20050239670A1 (en) * | 2004-04-21 | 2005-10-27 | Qing Stella | Personal care compositions that deposit hydrophilic benefit agents |
| US20070231355A1 (en) * | 2006-01-23 | 2007-10-04 | L'oreal | Cosmetic composition comprising multiphasic particles |
| DE102006027757A1 (en) * | 2006-06-16 | 2007-12-20 | Man Roland Druckmaschinen Ag | Cleaning agent in oil-in-water-pickering-emulsion form, useful e.g. to clean hard substrates such as metals, plastics and offset printing form, comprises buffer system, abrasive, solvents, non-polar solvent, water and further additives |
| JP5352117B2 (en) * | 2007-04-26 | 2013-11-27 | 株式会社 資生堂 | Oil-in-water emulsion composition and method for producing the same |
| US20090063334A1 (en) * | 2007-08-28 | 2009-03-05 | Alistair Duncan | Business-to-business transaction processing utilizing electronic payment network |
| DE102008051007A1 (en) | 2008-10-13 | 2010-04-15 | Beiersdorf Ag | Polyamide-5 compounds in cosmetic preparations |
| JP5427996B2 (en) * | 2009-10-19 | 2014-02-26 | サンノプコ株式会社 | Amphiphilic particles and method for producing the same |
| JP5427997B2 (en) * | 2010-02-02 | 2014-02-26 | サンノプコ株式会社 | Emulsified dispersion composition, production method thereof and amphiphilic particle aqueous dispersion |
| EP3673893A1 (en) | 2010-08-27 | 2020-07-01 | Sienna Biopharmaceuticals, Inc. | Compositions and methods for targeted thermomodulation |
| US9572880B2 (en) | 2010-08-27 | 2017-02-21 | Sienna Biopharmaceuticals, Inc. | Ultrasound delivery of nanoparticles |
| EP2714014A2 (en) * | 2011-06-03 | 2014-04-09 | Dow Global Technologies LLC | Encapsulated polar materials and methods of preparation |
| US9255180B2 (en) | 2012-06-28 | 2016-02-09 | Johnson & Johnson Consumer Inc. | Ultraviolet radiation absorbing polyethers |
| US20140004057A1 (en) | 2012-06-28 | 2014-01-02 | Johnson & Johnson Consumer Companies, Inc. | Sunscreen compositions containing an ultraviolet radiation-absorbing polyester |
| WO2014004477A2 (en) | 2012-06-28 | 2014-01-03 | Johnson & Johnson Consumer Companies, Inc. | Sunscreen compositions containing an ultraviolet radiation-absorbing polymer |
| US9469725B2 (en) | 2012-06-28 | 2016-10-18 | Johnson & Johnson Consumer Inc. | Ultraviolet radiation absorbing polymers |
| EP2906286B1 (en) | 2012-10-11 | 2017-06-14 | Nanocomposix, Inc. | Silver nanoplate compositions and methods |
| IL225985A0 (en) | 2013-04-25 | 2013-07-31 | Dov Ingman Prof | An improved cosmetic composition |
| US9452406B2 (en) | 2013-05-17 | 2016-09-27 | L'oreal | Bubble encapsulation via silicilic acid complexation |
| US10028895B2 (en) | 2013-05-17 | 2018-07-24 | L'oreal | Emulsion stabilization via silicilic acid complexation |
| US9433578B2 (en) | 2013-05-17 | 2016-09-06 | L'oreal | Stable bubbles via particle absorption by electrostatic interaction |
| WO2014184660A2 (en) | 2013-05-17 | 2014-11-20 | L'oreal | Emulsion stabilization |
| US10874603B2 (en) | 2014-05-12 | 2020-12-29 | Johnson & Johnson Consumer Inc. | Sunscreen compositions containing a UV-absorbing polyglycerol and a non-UV-absorbing polyglycerol |
| US20170027825A1 (en) * | 2015-06-30 | 2017-02-02 | Leorex Ltd. | Cosmetic composition |
| WO2017206047A1 (en) * | 2016-05-31 | 2017-12-07 | L'oreal | Translucent sunscreen composition with improved uv screening ability |
| KR102377585B1 (en) | 2016-06-16 | 2022-03-24 | 존슨 앤드 존슨 컨수머 인코포레이티드 | Sunscreen Composition Containing a Blend of a Linear Ultraviolet Radiation-Absorbing Polyether and Another Ultraviolet-Screening Compound |
| US10596087B2 (en) | 2016-10-05 | 2020-03-24 | Johnson & Johnson Consumer Inc. | Ultraviolet radiation absorbing polymer composition |
| JP6742637B2 (en) * | 2018-03-15 | 2020-08-19 | 学校法人神奈川大学 | Metal-resin composite dispersion, thermal barrier coating, method for producing metal-containing resin film or infrared reflective film using the same, and method for producing metal-resin composite dispersion |
| KR102711255B1 (en) * | 2021-10-26 | 2024-09-27 | 화성코스메틱 주식회사 | Emulsifier-free water-in-oil cosmetic composition |
| IT202200003131A1 (en) * | 2022-02-21 | 2023-08-21 | Unifarco S P A | Emulsifying composition stabilized by powders |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2208642A1 (en) * | 1972-12-05 | 1974-06-28 | Shiseido Co Ltd | Two-phase liquid cosmetic preparation - contg. oil water, a water- and oil-miscible organic liquid and finely divided insoluble solid particles |
| GB1579934A (en) | 1976-10-14 | 1980-11-26 | Beecham Group Ltd | Skin-care cosmetic products |
| NZ227813A (en) * | 1988-02-10 | 1990-03-27 | Richardson Vicks Inc | Oil in water emulsion having 3-40% oil and an amphipathic emulsifying agent in the range 0.02-2% and method of forming such emulsions |
| US5035890A (en) | 1989-04-10 | 1991-07-30 | Dow Corning Corporation | Emulsifier-free hand and body lotion |
| US5246780A (en) * | 1991-08-29 | 1993-09-21 | L'oreal | Coated particle for use in cosmetic preparations and method |
| US5643582A (en) | 1992-03-30 | 1997-07-01 | Smithkline Beecham Corporation | Moisturizer |
| DE4303983C2 (en) * | 1993-02-11 | 1998-01-22 | Beiersdorf Ag | Cosmetic and dermatological sunscreen formulations containing inorganic micropigments |
| FR2722116B1 (en) * | 1994-07-11 | 1996-08-23 | Oreal | OIL-IN-WATER EMULSION WITHOUT SURFACTANT, STABILIZED BY HOLLOW THERMOPLASTIC PARTICLES |
| US5534265A (en) | 1994-08-26 | 1996-07-09 | The Procter & Gamble Company | Thickened nonabrasive personal cleansing compositions |
| US5498407A (en) * | 1994-10-24 | 1996-03-12 | Atlas; Sheldon M. | Poly(2-hydroxyethyl methacrylate) and all copolymers of poly-HEMA fibers and cosmetic compositions containing same |
| FR2746302B1 (en) * | 1996-03-20 | 1998-12-24 | Oreal | COSMETIC COMPOSITIONS COMPRISING NANOPIGMENTS |
| DE19619837B4 (en) * | 1996-05-17 | 2007-03-08 | Beiersdorf Ag | Cosmetic or pharmaceutical preparations with reduced stickiness |
| FR2760641B1 (en) * | 1997-03-13 | 2000-08-18 | Oreal | STABLE OIL-IN-WATER EMULSION, MANUFACTURING METHOD THEREOF AND USE THEREOF IN THE COSMETIC AND DERMATOLOGICAL FIELDS |
| FR2768926B1 (en) * | 1997-10-01 | 2000-01-28 | Oreal | STABLE TOPICAL COMPOSITION CONTAINING A SOLID ORGANOPOLYSILOXANE ELASTOMERIC AND SPHERICAL PARTICLES |
| FR2781370B1 (en) * | 1998-07-07 | 2001-05-11 | Oreal | NOVEL COSMETIC COMPOSITIONS COMPRISING A FILM-FORMING POLYMER |
| DE19834819A1 (en) | 1998-08-01 | 2000-02-03 | Beiersdorf Ag | Emulsifier-free finely dispersed systems of the oil-in-water and water-in-oil type |
| US6165450A (en) * | 1999-05-03 | 2000-12-26 | Em Industries, Inc. | Sprayable sunscreen compositions |
-
1998
- 1998-08-01 DE DE19834819A patent/DE19834819A1/en not_active Withdrawn
-
1999
- 1999-07-22 US US09/744,494 patent/US6620407B1/en not_active Expired - Fee Related
- 1999-07-22 EP EP99936590A patent/EP1100431A1/en not_active Withdrawn
- 1999-07-22 WO PCT/EP1999/005242 patent/WO2000007548A1/en not_active Ceased
- 1999-07-22 JP JP2000563234A patent/JP2002522363A/en active Pending
Non-Patent Citations (1)
| Title |
|---|
| See references of WO0007548A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2002522363A (en) | 2002-07-23 |
| DE19834819A1 (en) | 2000-02-03 |
| US6620407B1 (en) | 2003-09-16 |
| WO2000007548A1 (en) | 2000-02-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1100433B1 (en) | Finely dispersed emulsifier-free systems of the oil-in-water and water-in-oil type, containing boron nitride | |
| EP1100431A1 (en) | Finely dispersed emulsifier-free systems of the oil-in-water and water-in-oil type | |
| EP0969802B1 (en) | Emulsifier-free finely dispersed systems of the water-in-oil type | |
| DE19842744B4 (en) | Emulsifier-free finely disperse oil-in-water and water-in-oil systems and their use | |
| EP0987001B1 (en) | Emulsifier-free finely dispersed systems of the oil-in-water or water-in-oil type | |
| EP0987002B1 (en) | Emulsifier-free finely dispersed systems of the oil-in-water or water-in-oil type | |
| EP0992233A2 (en) | Emulsifier-free finely dispersed systems of both water-in-oil and oil-in water type | |
| EP0987005A2 (en) | Emulsifier-free finely dispersed systems of the oil-in-water or water-in-oil type | |
| EP0987006B1 (en) | Emulsifier-free finely dispersed systems of the water-in-oil type | |
| EP0987007A2 (en) | Emulsifier-free finely dispersed systems of the oil-in-water or water-in-oil type | |
| DE19842767A1 (en) | Emulsifier-free finely dispersed systems of the oil-in-water and water-in-oil type | |
| EP1077058A2 (en) | Finely dispersed system of the type water-in-oil without emulsifiers | |
| EP1200039B1 (en) | Emulsifier-free finely dispersed water-in-oil-type systems | |
| EP1098624A1 (en) | Finely dispersed emulsifier-free systems of the oil-in-water and water-in-oil type | |
| EP1192937A2 (en) | Finely dispersed, low emulsifier systems of the type water-in-oil containing ethylcellulose | |
| EP0987004B1 (en) | Emulsifier-free finely dispersed systems of the oil-in-water or water-in-oil type | |
| EP1083861B1 (en) | Hydrous cosmetic or pharmaceutical sticks | |
| DE19939849A1 (en) | Emulsifier-free, finely dispersed water-in-oil systems |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20010111 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
| 17Q | First examination report despatched |
Effective date: 20030602 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20041207 |